Krzysztof Narkiewicz

Krzysztof Narkiewicz's AcademicInfluence.com Rankings

Mathematics

#5077

World Rank

#7182

Historical Rank

Number Theory

#126

World Rank

#167

Historical Rank

Measure Theory

#582

World Rank

#812

Historical Rank

mathematics Degrees

Download Badge

Mathematics

Krzysztof Narkiewicz's Degrees

PhD Mathematics University of Warsaw
Masters Mathematics University of Warsaw

Why Is Krzysztof Narkiewicz Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Krzysztof Narkiewicz's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) (2007) (9420)
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls (2007) (9208)
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). (2013) (6036)
2018 ESC/ESH Guidelines for the management of arterial hypertension. (2018) (5481)
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). (2007) (5476)
Genetic studies of body mass index yield new insights for obesity biology (2015) (3549)
Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids (2010) (3485)
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). (2007) (3077)
[2018 ESC/ESH Guidelines for the management of arterial hypertension]. (2019) (2445)
Genomewide association analysis of coronary artery disease. (2007) (2067)
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index (2010) (2011)
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study (2012) (2002)
2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. (2007) (1965)
Hundreds of variants clustered in genomic loci and biological pathways affect human height (2010) (1961)
Defining the role of common variation in the genomic and biological architecture of adult human height (2014) (1805)
Six new loci associated with body mass index highlight a neuronal influence on body weight regulation (2009) (1735)
[2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)]. (2018) (1684)
A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease (2015) (1567)
Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients (2000) (1551)
Large-scale association analysis identifies new risk loci for coronary artery disease (2012) (1507)
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document (2009) (1452)
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants (2007) (1421)
Common variants near MC4R are associated with fat mass, weight and risk of obesity (2008) (1307)
Association analyses of 249,796 individuals reveal eighteen new loci associated with body mass index (2010) (1179)
2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. (2013) (1115)
Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants (2009) (1100)
The task force for the management ofarterial hypertension of the european society ofhypertension (esh) and of the european society of cardiology (esc) (2013) (991)
2007 ESH‐ESC Guidelines for the management of arterial hypertension (2007) (921)
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease (2011) (894)
Genome-wide association analysis identifies 20 loci that influence adult height (2008) (816)
The 2013 ESH/ESC guidelines for the management of arterial hypertension (2013) (805)
Loss-of-function mutations in APOC3, triglycerides, and coronary disease. (2014) (799)
Identification of seven loci affecting mean telomere length and their association with disease (2013) (761)
2013 ESH/ESC Guidelines for the management of arterial hypertension (2013) (754)
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. (2009) (707)
Sequence variants at CHRNB3–CHRNA6 and CYP2A6 affect smoking behavior (2010) (688)
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies (2012) (646)
Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. (2009) (614)
Meta-analysis and imputation refines the association of 15q25 with smoking quantity (2010) (605)
Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls (2010) (600)
Mendelian randomization of blood lipids for coronary heart disease (2014) (580)
2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension (2014) (579)
Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture (2013) (568)
Altered cardiovascular variability in obstructive sleep apnea. (1998) (559)
A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium (2009) (551)
Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea. (1999) (523)
Sympathetic activity in obese subjects with and without obstructive sleep apnea. (1998) (514)
New susceptibility locus for coronary artery disease on chromosome 3q22.3 (2009) (510)
Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies (2011) (490)
Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease (2009) (484)
2018 Practice Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH/ESC Task Force for the Management of Arterial Hypertension. (2018) (476)
Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. (1999) (470)
Effects of Renal Sympathetic Denervation on Blood Pressure, Sleep Apnea Course, and Glycemic Control in Patients With Resistant Hypertension and Sleep Apnea (2011) (470)
Genome-wide association study of copy number variation in 16,000 cases of eight common diseases and 3,000 shared controls (2010) (465)
Effects of obstructive sleep apnea on endothelin-1 and blood pressure. (1999) (455)
[Sleep apnea and cardiovascular disease]. (2002) (428)
Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. (2000) (422)
Genetic Variants Influencing Circulating Lipid Levels and Risk of Coronary Artery Disease (2010) (417)
Concept, Design and Implementation of a Cardiovascular Gene-Centric 50 K SNP Array for Large-Scale Genomic Association Studies (2008) (416)
Bayesian refinement of association signals for 14 loci in 3 common diseases (2012) (416)
Repeated Replication and a Prospective Meta-Analysis of the Association Between Chromosome 9p21.3 and Coronary Artery Disease (2008) (410)
Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea. (1998) (396)
Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function (2016) (388)
Sex-stratified Genome-wide Association Studies Including 270,000 Individuals Show Sexual Dimorphism in Genetic Loci for Anthropometric Traits (2013) (365)
Sympathetic nerve activity in obstructive sleep apnoea. (2003) (355)
Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study. (2010) (352)
Gender-Selective Interaction Between Aging, Blood Pressure, and Sympathetic Nerve Activity (2005) (320)
Common variants near TERC are associated with mean telomere length (2010) (318)
Sequence variants at CHRNB 3 – CHRNA 6 and CYP 2 A 6 affect smoking behavior (2010) (312)
Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease. (2016) (309)
Effects of sleep deprivation on neural circulatory control. (2000) (307)
Chemoreflexes--physiology and clinical implications. (2003) (303)
ESH position paper: renal denervation - an interventional therapy of resistant hypertension. (2012) (274)
Telomere length of circulating leukocytes is decreased in patients with chronic heart failure. (2006) (269)
2018 Practice guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension (2018) (254)
Angiotensin Receptor Blockers May Increase Risk of Myocardial Infarction: Unraveling the ARB-MI Paradox (2006) (240)
Effect of CPAP on blood pressure in patients with OSA/hypopnea a systematic review and meta-analysis. (2014) (239)
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. (2012) (238)
The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study (2013) (235)
Dysfunctional nitric oxide signalling increases risk of myocardial infarction (2013) (234)
The sympathetic nervous system and obstructive sleep apnea: implications for hypertension (1997) (229)
Enhanced sympathetic and ventilatory responses to central chemoreflex activation in heart failure. (1999) (228)
Large-Scale Gene-Centric Analysis Identifies Novel Variants for Coronary Artery Disease (2011) (228)
Baroreflex control of sympathetic nerve activity and heart rate in obstructive sleep apnea. (1998) (223)
Genetically determined height and coronary artery disease. (2015) (220)
Mode of death in chronic heart failure. A request and proposition for more accurate classification. (1996) (209)
Systematic Evaluation of Pleiotropy Identifies 6 Further Loci Associated With Coronary Artery Disease (2017) (204)
Design of the Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Study: A Genome-Wide Association Meta-analysis Involving More Than 22 000 Cases and 60 000 Controls (2010) (203)
Sleep apnea: epidemiology, pathophysiology, and relation to cardiovascular risk. (2007) (202)
Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group ‘Hypertension Arrhythmias and Thrombosis’ of the European Society of Hypertension (2012) (200)
Genetic evidence of assortative mating in humans (2017) (199)
The Role of Adiposity in Cardiometabolic Traits: A Mendelian Randomization Analysis (2013) (199)
Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators. (1997) (198)
Association of Office and Ambulatory Blood Pressure With Mortality and Cardiovascular Outcomes. (2019) (198)
Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review (2002) (198)
Recommendations for the management of patients with obstructive sleep apnoea and hypertension (2013) (193)
Inheritance of coronary artery disease in men: an analysis of the role of the Y chromosome (2012) (191)
An evaluation of the beta‐1 adrenergic receptor Arg389Gly polymorphism in individuals with heart failure: a MERIT‐HF sub‐study (2003) (188)
Early vascular ageing in translation: from laboratory investigations to clinical applications in cardiovascular prevention. (2013) (184)
Cigarette smoking increases sympathetic outflow in humans. (1998) (177)
First Report of the Global SYMPLICITY Registry on the Effect of Renal Artery Denervation in Patients With Uncontrolled Hypertension (2015) (176)
Recent weight gain in patients with newly diagnosed obstructive sleep apnea. (1999) (172)
Cigarette Smoking Increases Sympathetic Outflow in Humans (1998) (170)
Phenotypic Characterization of Genetically Lowered Human Lipoprotein(a) Levels. (2016) (164)
A Genome-Wide Association Study Reveals Variants in ARL15 that Influence Adiponectin Levels (2009) (164)
Hypertension, Brain Damage and Cognitive Decline (2013) (160)
Obesity and hypertension--the issue is more complex than we thought. (2006) (160)
Relationship Between Muscle Sympathetic Nerve Activity and Diurnal Blood Pressure Profile (2002) (156)
Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative. (2010) (155)
Lifelong Reduction of LDL-Cholesterol Related to a Common Variant in the LDL-Receptor Gene Decreases the Risk of Coronary Artery Disease—A Mendelian Randomisation Study (2008) (154)
The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy (2010) (152)
Central vagotonic effects of atropine modulate spectral oscillations of sympathetic nerve activity. (1998) (151)
Genetic Regulation of Serum Phytosterol Levels and Risk of Coronary Artery Disease (2010) (151)
The Randomised Assessment of Treatment using Panel Assay of Cardiac Markers (RATPAC) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department (2010) (145)
An independent relationship between muscle sympathetic nerve activity and pulse wave velocity in normal humans (2010) (145)
Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry (2019) (142)
Sex differences in risk factors, treatment and mortality after acute myocardial infarction: an observational study (2000) (141)
A Genome-Wide Association Study Identifies LIPA as a Susceptibility Gene for Coronary Artery Disease (2011) (141)
The metabolic syndrome in hypertension: European society of hypertension position statement (2008) (138)
International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertension. (2013) (138)
Association of Rare and Common Variation in the Lipoprotein Lipase Gene With Coronary Artery Disease (2017) (135)
A genomewide linkage study of 1,933 families affected by premature coronary artery disease: The British Heart Foundation (BHF) Family Heart Study. (2005) (134)
Sustained Sympathetic and Blood Pressure Reduction 1 Year After Renal Denervation in Patients With Resistant Hypertension (2014) (133)
Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height. (2011) (133)
A Genome-Wide Association Study for Coronary Artery Disease Identifies a Novel Susceptibility Locus in the Major Histocompatibility Complex (2012) (131)
Heart-type fatty acid-binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values. (2007) (129)
Temporal trends in mortality of patients with diabetes mellitus suffering acute myocardial infarction: a comparison of over 3000 patients between 1995 and 2003. (2006) (129)
Adiposity as a cause of cardiovascular disease: a Mendelian randomization study. (2015) (128)
New Gender-Specific Partition Values for ECG Criteria of Left Ventricular Hypertrophy: Recalibration Against Cardiac MRI (2004) (124)
Non-dipping pattern of hypertension and obstructive sleep apnea syndrome (2010) (122)
Obstructive sleep apnea: an update on mechanisms and cardiovascular consequences. (2007) (119)
Evaluation of risk scores for risk stratification of acute coronary syndromes in the Myocardial Infarction National Audit Project (MINAP) database (2008) (118)
Sympathetic Activation by Sildenafil (2000) (112)
Variant ASGR1 Associated with a Reduced Risk of Coronary Artery Disease. (2016) (108)
Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis (2015) (106)
Plasma Lipid Composition and Risk of Developing Cardiovascular Disease (2013) (104)
An independent relationship between plasma leptin and heart rate in untreated patients with essential hypertension. (1999) (104)
QT dispersion as a predictor of long-term mortality in patients with acute myocardial infarction and clinical evidence of heart failure. (1999) (101)
Clinical characteristics of patients with resistant hypertension: the RESIST-POL study (2013) (101)
Arterial stiffness, central hemodynamics, and cardiovascular risk in hypertension (2011) (99)
Unilateral Carotid Body Resection in Resistant Hypertension (2016) (94)
Rosuvastatin: A Review of the Pharmacology and Clinical Effectiveness in Cardiovascular Disease (2012) (94)
Coronary Artery Disease–Associated Locus on Chromosome 9p21 and Early Markers of Atherosclerosis (2008) (93)
[ESH/ESC 2007 Guidelines for the management of arterial hypertension]. (2007) (91)
Poor prognosis of patients presenting with symptomatic myocardial infarction but without chest pain (2001) (90)
Hepatic Metabolism and Transporter Gene Variants Enhance Response to Rosuvastatin in Patients With Acute Myocardial Infarction: The GEOSTAT-1 Study (2010) (90)
Blood pressure control and cardiovascular risk profile in hypertensive patients from central and eastern European countries: results of the BP-CARE study. (2011) (89)
Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies. (2010) (89)
Hypertension types defined by clinic and ambulatory blood pressure in 14 143 patients referred to hypertension clinics worldwide. Data from the ARTEMIS study (2016) (88)
Trends in hospital treatments, including revascularisation, following acute myocardial infarction, 2003–2010: a multilevel and relative survival analysis for the National Institute for Cardiovascular Outcomes Research (NICOR) (2013) (86)
Hyperventilation alters arterial baroreflex control of heart rate and muscle sympathetic nerve activity. (2000) (82)
Increased genetic vulnerability to smoking at CHRNA5 in early-onset smokers. (2012) (81)
Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study. (2013) (80)
Interactive effect of cigarettes and coffee on daytime systolic blood pressure in patients with mild essential hypertension (1995) (80)
Sympathetic Neural Outflow and Chemoreflex Sensitivity Are Related to Spontaneous Breathing Rate in Normal Men (2006) (80)
Mechanisms of hypertension in the cardiometabolic syndrome (2009) (79)
Secretory Phospholipase A2-IIA and Cardiovascular Disease (2013) (78)
The impact of an electronic monitoring and reminder device on patient compliance with antihypertensive therapy: a randomized controlled trial (2010) (78)
Hypertension and sexual dysfunction: time to act. (2011) (76)
Prevalence of left ventricular diastolic dysfunction in European populations based on cross-validated diagnostic thresholds (2012) (76)
Tonic chemoreflex activation contributes to the elevated muscle sympathetic nerve activity in patients with chronic renal failure (2007) (76)
Genetic Predisposition to Higher Blood Pressure Increases Coronary Artery Disease Risk (2013) (75)
Gender bias in acute coronary syndromes. (2010) (75)
Evaluation of the NICE mini-GRACE risk scores for acute myocardial infarction using the Myocardial Ischaemia National Audit Project (MINAP) 2003–2009: National Institute for Cardiovascular Outcomes Research (NICOR) (2012) (72)
Investigation of the effect of Interleukin-1 receptor antagonist (IL-1ra) on markers of inflammation in non-ST elevation acute coronary syndromes (The MRC-ILA-HEART Study) (2008) (72)
Leptin interacts with heart rate but not sympathetic nerve traffic in healthy male subjects (2001) (71)
Human obesity is characterized by a selective potentiation of central chemoreflex sensitivity. (1999) (69)
Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial. (2014) (69)
Is smoking a causative factor of hypertension? (2005) (69)
Update on Hypertension Management: Obstructive sleep apnea and hypertension (2006) (69)
Cardiovascular effects of phentermine and topiramate: a new drug combination for the treatment of obesity (2014) (68)
Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART Study. (2010) (67)
Updated ESH position paper on interventional therapy of resistant hypertension. (2013) (67)
A simple benchmark for evaluating quality of care of patients following acute myocardial infarction (2001) (67)
Independent Association Between Plasma Leptin Levels and Heart Rate in Heart Transplant Recipients (2001) (67)
The RATPAC (Randomised Assessment of Treatment using Panel Assay of Cardiac markers) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department. (2011) (65)
2019 Guidelines on the management of diabetic patients. A position of Diabetes Poland (2019) (65)
Alcohol potentiates orthostatic hypotension : implications for alcohol-related syncope. (2000) (65)
The Relationship Between Plasma Angiopoietin-like Protein 4 Levels, Angiopoietin-like Protein 4 Genotype, and Coronary Heart Disease Risk (2010) (65)
Aortic Stiffness Predicts Functional Outcome in Patients After Ischemic Stroke (2012) (64)
Genetic analysis for a shared biological basis between migraine and coronary artery disease (2015) (64)
Protein-Truncating Variants at the Cholesteryl Ester Transfer Protein Gene and Risk for Coronary Heart Disease (2017) (64)
Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study (2013) (64)
Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study (2006) (64)
Importance of ventilation in modulating interaction between sympathetic drive and cardiovascular variability. (2001) (64)
Revelations About Carotid Body Function Through its Pathological Role in Resistant Hypertension (2013) (63)
Epidemiology and prevention of arterial hypertension in Poland (2005) (63)
Impact of obesity on cardiovascular health. (2013) (62)
Age- and Sex-Specific Causal Effects of Adiposity on Cardiovascular Risk Factors (2015) (62)
Heart rate variability and functional outcome in ischemic stroke: a multiparameter approach (2013) (62)
Rationale and design of a large registry on renal denervation: the Global SYMPLICITY registry. (2013) (62)
Diagnosis and management of hypertension in obesity (2006) (61)
Ambulatory blood pressure in mild hypertensive women taking oral contraceptives. A case-control study. (1995) (61)
Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data (2019) (61)
The myocardial infarction associated CDKN2A/CDKN2B locus on chromosome 9p21 is associated with stroke independently of coronary events in patients with hypertension (2009) (60)
The VEGF +405 CC promoter polymorphism is associated with an impaired prognosis in patients with chronic heart failure: a MERIT-HF substudy. (2005) (59)
Why study sympathetic nervous system? (2006) (59)
Hemodynamic and autonomic effects of smokeless tobacco in healthy young men. (2005) (59)
Impact and pitfalls of scaling of left ventricular and atrial structure in population-based studies (2016) (58)
β Blocker treatment and other prognostic variables in patients with clinical evidence of heart failure after acute myocardial infarction: evidence from the AIRE study (1999) (56)
Cognitive Dysfunction in Type 1 Diabetes Mellitus. (2019) (56)
Heritability of plasma leptin levels: a twin study. (1999) (56)
Renal Denervation in Resistant Hypertension and Obstructive Sleep Apnea: Randomized Proof-of-Concept Phase II Trial (2018) (55)
Association of frontal QRS-T angle--age risk score on admission electrocardiogram with mortality in patients admitted with an acute coronary syndrome. (2012) (54)
Follow-up study of patients randomly allocated ramipril or placebo for heart failure after acute myocardial infarction: AIRE Extension (AIREX) Study. Acute Infarction Ramipril Efficacy. (1997) (54)
The assessment of left ventricular hypertrophy in hypertension. (2006) (54)
Influences of gender on the interaction between sympathetic nerve traffic and central adiposity. (2008) (52)
Pulse wave velocity is associated with early clinical outcome after ischemic stroke. (2012) (52)
Chronic orthostatic intolerance: part of a spectrum of dysfunction in orthostatic cardiovascular homeostasis? (1998) (51)
Management of non-ST-elevation acute coronary syndromes: how cost-effective are glycoprotein IIb/IIIA antagonists in the UK National Health Service? (2005) (51)
2018 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (2018) (48)
Possible association between telomere length and renal dysfunction in patients with chronic heart failure. (2008) (48)
Smoking is associated with chronic sympathetic activation in hypertension (2010) (47)
Cardiovascular variability characteristics in obstructive sleep apnea (2001) (46)
Collaborative pooled analysis of data on C-reactive protein gene variants and coronary disease: judging causality by Mendelian randomisation (2008) (45)
Renal Denervation in High-Risk Patients With Hypertension. (2020) (45)
Heritability of plasma adiponectin levels and body mass index in twins. (2007) (44)
Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence (2014) (44)
The effects of statins on blood pressure in normotensive or hypertensive subjects--a meta-analysis of randomized controlled trials. (2013) (44)
An Investigation of CYP2D6 Genotype and Response to Metoprolol CR/XL During Dose Titration in Patients With Heart Failure: A MERIT‐HF Substudy (2014) (44)
Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk. (2018) (43)
Renin-angiotensin system modulation: the weight of evidence. (2005) (43)
Effects of acute and long-term slow breathing exercise on muscle sympathetic nerve activity in untreated male patients with hypertension (2013) (43)
The British Cardiac Society Working Group definition of myocardial infarction: implications for practice (2005) (42)
ACE inhibition, atherosclerosis and myocardial infarction--the AIRE Study in practice. Acute Infarction Ramipril Efficacy Study. (1994) (42)
An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals at risk of coronary events. A WOSCOPS substudy. (2002) (42)
Loss of Cardioprotective Effects at the ADAMTS7 Locus as a Result of Gene-Smoking Interactions (2017) (41)
Hypertension and cochlear hearing loss (2015) (41)
European Society of Hypertension Working Group on Obesity Obesity-induced hypertension and target organ damage: current knowledge and future directions. (2009) (41)
Predictors of in-hospital mortality for patients admitted with ST-elevation myocardial infarction: a real-world study using the Myocardial Infarction National Audit Project (MINAP) database (2007) (40)
Left Ventricle Mass Index and the Common, Functional, X-Linked Angiotensin II Type-2 Receptor Gene Polymorphism (−1332 G/A) in Patients With Systemic Hypertension (2004) (40)
Obstructive sleep apnea as a cause of neurogenic hypertension (1999) (40)
Detection of low- and high-frequency rhythms in the variability of skin sympathetic nerve activity. (2000) (40)
Validation of primary and secondary outcomes and classification of mode of death among patients with clinical evidence of heart failure after a myocardial infarction: a report from the Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. (1993) (40)
The effects of short-term passive smoke exposure on endothelium-dependent and independent vasodilation. (1999) (40)
Intensive blood pressure lowering prevents mild cognitive impairment and possible dementia and slows development of white matter lesions in brain: the SPRINT Memory and Cognition IN Decreased Hypertension (SPRINT MIND) study (2018) (40)
Cost-effectiveness of alternative strategies for the initial medical management of non-ST elevation acute coronary syndrome: systematic review and decision-analytical modelling. (2005) (39)
A new technique with high reproducibility to estimate renal oxygenation using BOLD-MRI in chronic kidney disease. (2015) (38)
European Society of Hypertension Working Group on Obesity: background, aims and perspectives. (2007) (38)
The clinical significance of a common, functional, X-linked angiotensin II type 2-receptor gene polymorphism (-1332 G/A) in a cohort of 509 families with premature coronary artery disease. (2005) (37)
Interactive effect of heart rate and muscle sympathetic nerve activity on blood pressure. (1999) (36)
The SPRINT study: Outcome may be driven by difference in diuretic treatment demasking heart failure and study design may support systolic blood pressure target below 140 mmHg rather than below 120 mmHg (2016) (36)
2015 guidelines for the management of hypertension. Recommendations of the Polish Society of Hypertension - short version. (2015) (36)
Assessment of adherence to treatment in patients with resistant hypertension using toxicological serum analysis. A subgroup evaluation of the RESIST-POL study. (2015) (36)
The J-curve phenomenon revisited again: SPRINT outcomes favor target systolic blood pressure below 120 mmHg (2016) (36)
High-normal blood pressure is associated with increased resting sympathetic activity but normal responses to stress tests (2013) (35)
Subgroup and per-protocol analyses from the Hypertension in the Very Elderly Trial (2014) (35)
European Society of Hypertension Scientific Newsletter: Update on Hypertension Management (2007) (35)
Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease. (2016) (34)
Sympathetic neural responses to smoking are age dependent (2006) (34)
Ordinal pattern statistics for the assessment of heart rate variability (2013) (33)
Distinct Loci in the CHRNA5/CHRNA3/CHRNB4 Gene Cluster Are Associated With Onset of Regular Smoking (2013) (33)
Sympathetic rhythmicity in cardiac transplant recipients. (1999) (33)
Angiotensin Receptor Blockers Do Not Reduce Risk of Myocardial Infarction, Cardiovascular Death, or Total Mortality: Further Evidence for the ARB-MI Paradox. (2017) (33)
Funnel plots, performance variation and the Myocardial Infarction National Audit Project 2003–2004 (2006) (32)
Novel Loci Associated with Increased Risk of Sudden Cardiac Death in the Context of Coronary Artery Disease (2013) (32)
Characterization of insomnia in patients with essential hypertension (2006) (32)
Serum 99th centile values for two heart-type fatty acid binding protein assays (2009) (32)
An assessment of composite measures of hospital performance and associated mortality for patients with acute myocardial infarction. Analysis of individual hospital performance and outcome for the National Institute for Cardiovascular Outcomes Research (NICOR) (2013) (32)
Guía de práctica clínica de la ESH/ESC para el manejo de la hipertensión arterial (2013) (2013) (32)
Treatment of high blood pressure in elderly and octogenarians: European Society of Hypertension statement on blood pressure targets (2016) (32)
The Divergent Cardiovascular Effects of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Myocardial Infarction and Death. (2016) (31)
Sibutramine and its cardiovascular profile (2002) (31)
Real-time monitoring of coronary care mortality: a comparison and combination of two monitoring tools. (2005) (30)
Quality of life trajectories in survivors of acute myocardial infarction: a national longitudinal study (2019) (30)
The Acute Infarction Ramipril Efficacy (AIRE) Study: Rationale, Design, Organization, and Outcome Definitions (1991) (30)
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke. (2016) (29)
Guía ESC/ESH 2018 sobre el diagnóstico y tratamiento de la hipertensión arterial (2019) (29)
Effects of angiotensin-converting enzyme inhibitors and beta blockers on clinical outcomes in patients with and without coronary artery obstructions at angiography (from a Register-Based Cohort Study on Acute Coronary Syndromes). (2014) (29)
Factors associated with resistant hypertension in a large cohort of hypertensive patients: the Pol-Fokus study. (2015) (28)
Effects of Peripheral Chemoreceptors Deactivation on Sympathetic Activity in Heart Transplant Recipients (2005) (28)
Angiotensin-converting enzyme inhibitors after myocardial infarction: indications and timing. (1995) (28)
Adherence to coronary artery disease secondary prevention medicines: exploring modifiable barriers (2019) (27)
A randomized, controlled trial of simvastatin versus rosuvastatin in patients with acute myocardial infarction: the Secondary Prevention of Acute Coronary Events – Reduction of Cholesterol to Key European Targets Trial (2009) (27)
The incomplete Bucindolol Evaluation in Acute myocardial infarction Trial (BEAT) (2002) (27)
Relationship between heart rate variability, blood pressure and arterial wall properties during air and oxygen breathing in healthy subjects (2013) (26)
Personality Type and Neural Circulatory Control (2000) (26)
Prolonged head down bed rest-induced inactivity impairs tonic autonomic regulation while sparing oscillatory cardiovascular rhythms in healthy humans (2009) (26)
Blood pressure medication should not be routinely dosed at bedtime. We must disregard the data from the HYGIA project (2020) (26)
Obstructive sleep apnea and hypertension (2005) (25)
Effect of beta-blocker therapy on heart rate response in patients with hypertension and newly diagnosed untreated obstructive sleep apnea syndrome. (2016) (25)
Doppler indexes of left ventricular systolic and diastolic function in relation to the arterial stiffness in a general population (2016) (25)
No Association of Coronary Artery Disease with X-Chromosomal Variants in Comprehensive International Meta-Analysis (2016) (25)
Resting sympathetic outflow does not predict the morning blood pressure surge in hypertension (2011) (25)
Hyperglycaemia, in relation to sex, and mortality after acute coronary syndrome (2007) (25)
Cardiovascular End Points and Mortality Are Not Closer Associated With Central Than Peripheral Pulsatile Blood Pressure Components (2020) (24)
An evaluation of inflammatory gene polymorphisms in sibships discordant for premature coronary artery disease: the GRACE-IMMUNE study (2010) (24)
Cardiovascular End Points and Mortality Are Not Closer Associated With Central Than Peripheral Pulsatile Blood Pressure Components (2020) (24)
Diabetes Mellitus and Mortality after Acute Coronary Syndrome as a First or Recurrent Cardiovascular Event (2008) (23)
Guidelines for the Management of Hypertension (2015) (23)
Relationship between fasting plasma insulin and ambulatory blood pressure in young, non-obese normotensive subjects. (1991) (23)
SPARTE Study: Normalization of Arterial Stiffness and Cardiovascular Events in Patients With Hypertension at Medium to Very High Risk (2021) (23)
Obstructive sleep apnea and intermittent hypoxia increase expression of dual specificity phosphatase 1. (2013) (23)
Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk: 2021 update. (2021) (22)
Asymmetric features of short-term blood pressure variability (2010) (22)
Potentiated sympathetic and hemodynamic responses to alcohol in hypertensive vs. normotensive individuals (2011) (22)
Ramipril reduces QT dispersion in patients with acute myocardial infarction and heart failure. (1999) (22)
Genetic determinants of plasma ACE and renin activity in young normotensive twins. (1999) (22)
Impact of abdominal obesity on the frequency of hypertension and cardiovascular disease in Poland – Results from the IDEA study (International Day for the Evaluation of Abdominal Obesity) (2011) (22)
Compensatory functional reorganization may precede hypertension-related brain damage and cognitive decline: a functional magnetic resonance imaging study (2017) (22)
A randomized and controlled study of noninvasive hemodynamic monitoring as a guide to drug treatment of uncontrolled hypertensive patients (2015) (21)
Age-dependent inequalities in improvements in mortality occur early after acute myocardial infarction in 478,242 patients in the Myocardial Ischaemia National Audit Project (MINAP) registry. (2013) (21)
Acute hypertensive response in ischemic stroke is associated with increased aortic stiffness. (2016) (21)
Ambulatory blood pressure and long-term risk for atrial fibrillation (2018) (21)
Impaired baroreflex sensitivity as a potential marker of cardiovascular risk in hypertension. (2008) (20)
Editorial [Hot topic: Controversies in Hypertension Treatment (Guest Editors: Maciej Banach, Sverre E. Kjeldsen and Krzysztof Narkiewicz)] (2010) (20)
Exercise testing soon after myocardial infarction: its relation to course and outcome at one year in patients aged less than 55 years. (1989) (20)
Impact of slow breathing on the blood pressure and subarachnoid space width oscillations in humans (2019) (20)
Smoking and obesity associated BDNF gene variance predicts total and cardiovascular mortality in smokers (2013) (20)
Change in serum lipids after acute coronary syndromes: secondary analysis of SPACE ROCKET study data and a comparative literature review. (2010) (19)
Entropy Measures in the Assessment of Heart Rate Variability in Patients with Cardiodepressive Vasovagal Syncope (2015) (19)
Left ventricular function after takotsubo is not fully recovered in long-term follow-up: A speckle tracking echocardiography study. (2017) (19)
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial (2022) (19)
Kidney function in the very elderly with hypertension: data from the hypertension in the very elderly (HYVET) trial. (2013) (19)
Relationship between selected DNA polymorphisms and coronary artery disease complications. (2017) (19)
Renal denervation reduces office and ambulatory heart rate in patients with uncontrolled hypertension: 12-month outcomes from the global SYMPLICITY registry (2016) (19)
Renal artery denervation for treatment of patients with self-reported obstructive sleep apnea and resistant hypertension: results from the Global SYMPLICITY Registry (2017) (19)
State of global health – hypertension burden and control (2012) (19)
Opposing Age-Related Trends in Absolute and Relative Risk of Adverse Health Outcomes Associated With Out-of-Office Blood Pressure. (2019) (19)
Survey of patient and physician assessment of a compliance reminder device in the treatment of hypertension (2009) (18)
An evaluation of composite indicators of hospital acute myocardial infarction care: a study of 136,392 patients from the Myocardial Ischaemia National Audit Project. (2013) (18)
Comparison of home and office blood pressure in hypertensive patients treated with zofenopril or losartan (2007) (18)
Genetic influences on insulinemia in normotensive twins. (1997) (18)
Clinical and analytical evaluation of an immunoturbidimetric heart-type fatty acid-binding protein assay (2013) (17)
beta-2-adrenergic receptor gene polymorphism confers susceptibility to Graves disease. (2007) (17)
An evidence-based approach to the assessment of heart-type Fatty Acid binding protein in acute coronary syndrome. (2012) (17)
Ischemic heart disease in women: are there sex differences in pathophysiology and risk factors?: position paper from the Working Group on Coronary Pathophysiology Microcirculation of the European Society of Cardiology (2019) (17)
Effect of a common X-linked angiotensin II type 2-receptor gene polymorphism (-1332 G/A) on the occurrence of premature myocardial infarction and stenotic atherosclerosis requiring revascularization. (2007) (17)
Update of the position paper on arterial hypertension and erectile dysfunction. (2020) (17)
Left ventricular ejection fraction and aortic stiffness are independent predictors of neurological outcome in acute ischemic stroke (2016) (17)
Recommendation for the management of dyslipidemia in Poland - Third Declaration of Sopot. Interdisciplinary Expert Position Statement endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy. (2018) (17)
A twin study of heritability of plasma lipoprotein-associated phospholipase A2 (Lp-PLA2) mass and activity. (2009) (17)
Subclinical Mood and Cognition Impairments and Blood Pressure Control in a Large Cohort of Elderly Hypertensives. (2016) (17)
Enhanced linkage of a locus on chromosome 2 to premature coronary artery disease in the absence of hypercholesterolemia (2007) (16)
Outcome-Driven Thresholds for Ambulatory Blood Pressure Based on the New American College of Cardiology/American Heart Association Classification of Hypertension. (2019) (16)
Relation between family history of hypertension, overweight and ambulatory blood pressure: the HARVEST study. (1995) (16)
Secretory Phospholipase A2-IIA and Cardiovascular Disease A Mendelian Randomization Study (2017) (16)
Metabolomic Signature of Early Vascular Aging (EVA) in Hypertension (2020) (16)
The heart rate hypothesis: ready to be tested (2008) (16)
Hypertension is associated with dysfunction of both peripheral and central auditory system (2016) (16)
An assessment of the concentration-related prognostic value of cardiac troponin I following acute coronary syndrome. (2011) (16)
Controversies in hypertension treatment. (2010) (16)
Theophylline Therapy for Near-Fatal Cheyne–Stokes Respiration: A Case Report (1999) (16)
Antihypertensive efficacy and safety of olmesartan and ramipril in elderly patients with mild to moderate systolic and diastolic essential hypertension (2011) (16)
Wavelet transform analysis to assess oscillations in pial artery pulsation at the human cardiac frequency. (2015) (15)
2015 Guidelines for the Management of Hypertension (2015) (15)
Renal denervation in patients with versus without chronic kidney disease: results from the global SYMPLICITY Registry with follow-up data of 3 years. (2021) (15)
Longitudinal tracking of muscle sympathetic nerve activity and its relationship with blood pressure in subjects with prehypertension (2016) (15)
Are fasting plasma homocyst(e)ine levels heritable? A study of normotensive twins. (2000) (15)
Setting-up a blood pressure and vascular protection clinic: requirements of the European Society of Hypertension. (2010) (15)
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial. (2022) (15)
New 2017 American Heart Association and American College of Cardiology guideline for hypertension in the adults: major paradigm shifts, but will they help to fight against the hypertension disease burden? (2018) (15)
An evaluation of 20 year survival in patients with diabetes mellitus and acute myocardial infarction. (2016) (15)
Blood pressure in acute ischemic stroke: challenges in trial interpretation and clinical management position of the ESH Working Group on Hypertension and the Brain (2018) (15)
Aging and Hypertension – Independent or Intertwined White Matter Impairing Factors? Insights From the Quantitative Diffusion Tensor Imaging (2019) (15)
Hypertension and cardiovascular disease in women: Progress towards better understanding of gender‐specific differences? (2006) (14)
A Case for Less Intensive Blood Pressure Control: It Matters to Achieve Target Blood Pressure Early and Sustained Below 140/90mmHg. (2016) (14)
Smoking and cardiovascular risk: new mechanisms and further evidence for a ‘guilty’ verdict (2004) (14)
Proteomic-Biostatistic Integrated Approach for Finding the Underlying Molecular Determinants of Hypertension in Human Plasma (2017) (14)
Hypertension in the metabolic syndrome: summary of the new position statement of the European Society of Hypertension. (2009) (14)
A COST-EFFECTIVENESS MODEL COMPARING ALTERNATIVE MANAGEMENT STRATEGIES FOR THE USE OF GLYCOPROTEIN IIB/IIIA ANTAGONISTS IN NON-ST- ELEVATION ACUTE CORONARY SYNDROME (2007) (14)
Potential protective effects of antihypertensive treatments during the Covid-19 pandemic: from inhibitors of the renin-angiotensin system to beta-adrenergic receptor blockers (2020) (14)
TREATMENT OF HYPERTENSION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) (2012) (14)
RESPONSE TO ORTHOSTATIC STRESS PREDICTS OFFICE‐DAYTIME BLOOD PRESSURE DIFFERENCE, BUT NOT NOCTURNAL BLOOD PRESSURE FALL IN MILD ESSENTIAL HYPERTENSIVES: RESULTS OF THE HARVEST TRIAL (1995) (14)
Acute hypoxia diminishes the relationship between blood pressure and subarachnoid space width oscillations at the human cardiac frequency (2017) (13)
Heightened acute circulatory responses to smoking in women (2008) (13)
Circadian variations in blood pressure and their implications for the administration of antihypertensive drugs: is dosing in the evening better than in the morning? (2020) (13)
Expertise: no longer a sine qua non for guideline authors? (2017) (13)
Optimizing the Management of Uncontrolled/Resistant Hypertension. The Importance of Sleep Apnoea Syndrome. (2017) (13)
Attempt to eliminate health inequalities in Poland arising at the time of political and economic transformation: Polish 400 Cities Project (2006) (13)
Long-term effects of device-guided slow breathing in stable heart failure patients with reduced ejection fraction (2018) (13)
The lipoprotein lipase gene serine 447 stop variant influences hypertension-induced left ventricular hypertrophy and risk of coronary heart disease. (2007) (13)
The Global Burden of Disease Study 2015 and Blood Pressure (2017) (12)
2019 Guidelines for the Management of Hypertension — Part 1–7 (2019) (12)
Missing Verification of Source Data in Hypertension Research (2021) (12)
Twenty‐four‐hour and conventional blood pressure components and risk of preterm delivery or neonatal complications in gestational hypertension (2009) (12)
Blood Pressure Management in Acute Ischemic Stroke (2020) (12)
CrossTalk opposing view: Which technique for controlling resistant hypertension? Carotid chemoreceptor denervation/modulation (2014) (12)
Inﬂuence of Sleep and Sleep Apnea on Autonomic Control of the Cardiovascular System (2000) (12)
Association of Fatal and Nonfatal Cardiovascular Outcomes With 24-Hour Mean Arterial Pressure (2020) (11)
What to expect from ACE inhibitors after myocardial infarction. (1994) (11)
The use of single-pill combinations as first-line treatment for hypertension: translating guidelines into clinical practice. (2020) (11)
Recent advances in the pathophysiology of arterial hypertension - potential implications for clinical practice. (2017) (11)
The Divergent Cardiovascular Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Type 1 Receptor Blockers in Adult Patients With Type 2 Diabetes Mellitus. (2017) (11)
The INTERSTROKE Study: hypertension is by far the most important modifiable risk factor for stroke (2017) (11)
The effect of referral for cardiac rehabilitation on survival following acute myocardial infarction: a comparison survival in two cohorts collected in 1995 and 2003 (2014) (11)
Sympathetic nervous system and arterial hypertension: new perspectives, new data. (2013) (11)
Moderate-to-severe obstructive sleep apnea is associated with telomere lengthening. (2017) (11)
Competence of Polish primary-care doctors in the pharmacological treatment of hypertension. (2010) (11)
Structure and in vitro function of human subcutaneous small arteries in mild heart failure. (1998) (11)
Association of cardiac rehabilitation and health-related quality of life following acute myocardial infarction (2020) (11)
Meta-analysis of individual patient data from trials of long-term ACE-inhibitor treatment after acute myocardial infarction (SAVE, AIRE, and TRACE studies) (1997) (11)
Awareness and treatment of arterial hypertension in Poland. (1996) (10)
Re-engineering the post-myocardial infarction medicines optimisation pathway: a retrospective analysis of a joint consultant pharmacist and cardiologist clinic model (2018) (10)
Pial artery and subarachnoid width response to apnoea in normal humans (2015) (10)
Orogenic Andesites and Plate Tectonics (1982) (10)
European Society of Hypertension Working Group on Obesity: obesity drugs and cardiovascular outcomes. (2011) (10)
Angiotensin receptor blockers should be regarded as first-line drugs for stroke prevention in both primary and secondary prevention settings: no. (2009) (10)
Pharmacological characterization of the dopamine receptor coupled to cyclic AMP formation expressed by rat mesenteric artery vascular smooth muscle cells in culture (1993) (10)
Lipids, Blood Pressure, Kidney-what was New in 2012? (2012) (10)
Health economy of the metabolic syndrome pandemic (2005) (10)
[Actual problems of dyslipidaemia treatment in Poland - 2nd Declaration of Sopot. Experts' Group Consensus endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy]. (2014) (10)
10Kin1day: A Bottom-Up Neuroimaging Initiative (2019) (10)
Evaluation of the Methods and Management of Acute Coronary Events (EMMACE)-3: protocol for a longitudinal study (2015) (10)
Telomere Length and Risk of Major Adverse Cardiac Events and Cancer in Obstructive Sleep Apnea Patients (2019) (10)
Analysis of Gene-Gene Interactions among Common Variants in Candidate Cardiovascular Genes in Coronary Artery Disease (2015) (10)
Characterization of the dopamine receptor expressed by rat glomerular mesangial cells in culture. (1992) (10)
Antihypertensive therapy in the obese hypertensive patient (2006) (10)
Obesity-related hypertension: relevance of vascular responses to mental stress. (2002) (10)
Disregard the reported data from the HYGIA project: blood pressure medication not to be routinely dosed at bedtime. (2020) (10)
More about the “ARB MI paradox” (2007) (9)
TCT-761 Long-term (3-year) safety and effectiveness from the Global SYMPLICITY Registry of renal denervation in a real world patient population with uncontrolled hypertension. (2016) (9)
Ambulatory systolic blood pressure is related to the deletion allele of the angiotensin I converting enzyme gene in young normotensives with parental history of hypertension. (1998) (9)
No effect of genetic variation at the angiotensinogen locus on ambulatory blood pressure level in normotensive subjects. (1997) (9)
Prevalence and distribution of left ventricular diastolic dysfunction in treated patients with long-lasting hypertension (2018) (9)
Increased inspiratory resistance affects the dynamic relationship between blood pressure changes and subarachnoid space width oscillations (2017) (9)
Universal definition of myocardial infarction (2008) (9)
Epilepsy and hypertension: The possible link for sudden unexpected death in epilepsy? (2020) (9)
The J-curve phenomenon revisited (2009) (9)
Untargeted Metabolomics Provides Insight into the Mechanisms Underlying Resistant Hypertension. (2019) (9)
Relative and Absolute Risk to Guide the Management of Pulse Pressure, an Age-Related Cardiovascular Risk Factor (2021) (9)
Lack of association of genetic variants in the LRP8 gene with familial and sporadic myocardial infarction (2008) (9)
Impact of aspirin and statins on long‐term survival in patients hospitalized with acute myocardial infarction complicated by heart failure: an analysis of 1706 patients (2014) (9)
Identifying acute myocardial infarction: effects on treatment and mortality, and implications for National Service Framework audit. (2003) (9)
Improving patient compliance with hypertension treatment: mission possible? (2010) (9)
Aortic stiffness is not only associated with structural but also functional parameters of retinal microcirculation. (2020) (9)
Cumulative effects of common genetic variants on risk of sudden cardiac death (2015) (8)
Relationship between gender and clinical characteristics, associated factors, and hypertension treatment in patients with resistant hypertension. (2017) (8)
Statistical profiling of hospital performance using acute coronary syndrome mortality (2012) (8)
Sympathetic Activation in Chronic Heart Failure: Potential Benefits of Interventional Therapies (2016) (8)
Do we know more about hypertension in Poland after the May Measurement Month 2017?—Europe (2019) (8)
Effects of renal sympathetic denervation on blood pressure and glycaemic control in patients with true resistant hypertension: results of Polish Renal Denervation Registry (RDN-POL Registry). (2016) (8)
Target blood pressure in elderly hypertensive patients and in patients with diabetes mellitus. (2014) (8)
Challenges in oscillometric blood pressure measurement in atrial fibrillation: looking for practical solutions (2018) (8)
Correction: Lifelong Reduction of LDL-Cholesterol Related to a Common Variant in the LDL-Receptor Gene Decreases the Risk of Coronary Artery Disease—A Mendelian Randomisation Study (2008) (7)
Risk Stratification by Cross-Classification of Central and Brachial Systolic Blood Pressure (2022) (7)
The accuracy of SpaceLabs 90207 in blood pressure monitoring in patients with atrial fibrillation (2018) (7)
Epilepsy and hypertension: The possible link for SUDEP? (2013) (7)
HOPE-3, SPRINT, VALUE and a meta-analysis of trials in patients with diabetes support treatment of hypertension to a target below 140 mmHg (2016) (7)
Impact of orthostatic hypotension and antihypertensive drug treatment on total and cardiovascular mortality in a very elderly community-dwelling population (2019) (7)
Central sympathetic nervous system reinforcement in obstructive sleep apnoea. (2017) (7)
An evaluation of the relationship between specialist training in cardiology and implementation of evidence-based care of patients following acute myocardial infarction. (2004) (7)
The Combination of Beta-Blockers and ACE Inhibitors Across the Spectrum of Cardiovascular Diseases (2021) (7)
Practical Applications for Single Pill Combinations in the Cardiovascular Continuum. (2017) (7)
The Combination of Beta-Blockers and ACE Inhibitors Across the Spectrum of Cardiovascular Diseases (2021) (7)
[Catheter-based renal sympathetic denervation for the treatment of resistant arterial hypertension in Poland - experts consensus statement]. (2011) (7)
Blood pressure lowering effect of renal sympathetic denervation or placebo? - building expectations for Symplicity-HTN 3 (2013) (7)
New data on antihypertensive drugs and risk of cancer: should we worry? (2019) (7)
Renal denervation in treatment-resistant hypertension – Oslo RDN, Symplicity HTN-3 and INSPiRED randomized trials (2014) (7)
Genetic risk factors influence nighttime blood pressure and related cardiovascular complications in patients with coronary heart disease (2018) (7)
Rapid appraisal of clinicians' reactions to guidance from the National Institute of clinical Excellence on use of glycoprotein IIb/IIIa antagonists for acute coronary syndromes (2002) (7)
Hypertension control – A global challenge (2005) (7)
Primary Aldosteronism and Obstructive Sleep Apnea: A Cross-Sectional Multi-Ethnic Study. (2019) (7)
Tissue Doppler indexes of left ventricular systolic function in relation to the pulsatile and steady components of blood pressure in a general population (2012) (6)
Angiotensin receptor - neprilysin inhibiton (ARNI) – A novel therapeutic concept for management of hypertension and heart failure (2012) (6)
Metabolic syndrome – a new definition and management guidelines (2022) (6)
Acute Effects of Electronic and Tobacco Cigarette Smoking on Sympathetic Nerve Activity and Blood Pressure in Humans (2022) (6)
Who should be treated with angiotensin-converting enzyme inhibitors after myocardial infarction? (1996) (6)
General practitioners ignore high normal blood pressure (2008) (6)
Cuff-less measurements of blood pressure: are we ready for a change? (2021) (6)
Serum of obstructive sleep apnea patients impairs human coronary endothelial cell migration (2015) (6)
Cardiac functional benefits of ivabradine therapy in patients with severe heart failure. (2013) (6)
Urinary proteomics combined with home blood pressure telemonitoring for health care reform trial: rational and protocol (2020) (6)
Visualizing Carotid Bodies With Doppler Ultrasound Versus CT Angiography: Preliminary Study. (2017) (6)
RAAS inhibition – a practice of medical progress (2006) (6)
Clinical characteristics, antihypertensive medication use and blood pressure control among patients with treatment-resistant hypertension: the Survey of PatIents with treatment ResIstant hyperTension study. (2019) (6)
External validation, extension and recalibration of Braunwald's simple risk index in a community-based cohort of patients with both STEMI and NSTEMI. (2006) (6)
Awareness of hypertension guidelines in primary healthcare in Poland (2007) (6)
The my experience of taking medicines (MYMEDS) questionnaire for assessing medicines adherence barriers in post-myocardial infarction patients: development and utility (2020) (6)
An American TROPHY in the prevention of hypertension (2006) (6)
Theophylline Therapy for Near-Fatal CheyneStokes Respiration: A Case Report (1999) (6)
A multilocus genetic risk score is associated with arterial stiffness in hypertensive patients: the CARE NORTH study (2018) (6)
Inhibition of the renin-angiotensin system after acute myocardial infarction—treat first, select later? (1996) (6)
Heteroplasmic mitochondrial DNA variants in cardiovascular diseases (2022) (5)
Competence of General Practitioners in Giving Advice about Changes in Lifestyle to Hypertensive Patients (2009) (5)
Do angiotensin receptor blockers increase the risk of myocardial infarction? Angiotensin Receptor Blockers May Increase Risk of Myocardial Infarction C ONTROVERSIES IN C ARDIOVASCULAR M EDICINE (2006) (5)
ESH Hypertension Excellence Centres: a new strategy to combat an old foe. (2007) (5)
7D.11: RETINAL ARTERIOLAR STRUCTURE IN PATIENTS WITH PRIMARY ALDOSTERONISM (2015) (5)
Systolic blood pressure control prevents cognitive decline and slows development of white matter lesions in the brain: the SPRINT MIND study outcomes (2019) (5)
Heritability and other determinants of left ventricular diastolic function in the family-based population study (2014) (5)
Will we ever use angiotensin receptor neprilysin inhibition (ARNi) for the treatment of hypertension? (2019) (5)
Theophylline therapy for Cheyne-Stokes respiration during sleep in a 41-year-old man with refractory arterial hypertension. (2014) (5)
Non-invasive hemodynamic monitoring as a guide to drug treatment of uncontrolled hypertensive patients: effects on home blood pressure in the BEAUTY study (2018) (5)
Second-hand smoke--a license to kill due to expire. (2007) (5)
New ESH/ESC Guidelines Signal Progress in Hypertension Management (2007) (5)
The competence of primary care doctors in the investigation of patients with elevated blood pressure: results of a cross-sectional study using clinical vignettes. (2010) (5)
Single-pill combinations (SPCs) and treatment of arterial hypertension in Poland. Expert consensus statement of the Polish Society of Hypertension and Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy. (2017) (5)
Blood pressure and migration (2010) (5)
Angiotensin II receptor blocker combinations: From guidelines to clinical practice (2012) (5)
Current understanding of the effects of inspiratory resistance on the interactions between systemic BP, cerebral perfusion, ICP and CSF dynamics. (2019) (5)
Lumen narrowing and increased wall to lumen ratio of retinal microcirculation are valuable biomarkers of hypertension-mediated cardiac damage (2019) (5)
HIGH RISK PATIENTS BENEFIT MOST FROM THE SMS-BASED INTERVENTION: PP.20.272 (2010) (5)
Age-dependent sympathetic neural responses to ß1 selective beta-blockade in untreated hypertension-related tachycardia (2018) (5)
Insufficiency of the zona glomerulosa of the adrenal cortex and progressive kidney insufficiency following unilateral adrenalectomy – case report and discussion (2018) (5)
Should we treat prehypertension? (2009) (5)
Blood pressure reduction and clinical outcomes with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: protocol for a systematic review and meta-regression analysis (2018) (4)
Which Target Blood Pressure in Year 2018? Evidence from Recent Clinical Trials (2018) (4)
Cardiovascular Risk Reduction After Renal Denervation According to Time in Therapeutic Systolic Blood Pressure Range. (2022) (4)
Prevalence and characteristics of OSAFED syndrome in atrial fibrillation primary care patients. (2017) (4)
Awareness of the role of cardiovascular risk factors and their prevention from the perspective of Tricity adolescents (2017) (4)
Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a prospective multicentre cohort study (2022) (4)
Prevention of heart failure mortality and hospitalizations in SPRINT, EMPA-REG, ALLHAT and HYVET: are diuretics the clue? (2017) (4)
[Practice guidelines 2007 for the treatment of arterial hypertension]. (2007) (4)
Beta‐blockers as sub‐optimal treatment for hypertension: Time for first‐line therapy revision? (2006) (4)
The Acute Infarction Ramipril Efficacy (AIRE) Study: rationale, design, organization, and outcome definitions. (1991) (4)
Renal nerve ablation: Emerging role in therapeutics (2011) (4)
May Measurement Month 2018: an analysis of blood pressure screening campaign results from Poland (2020) (4)
P-45: The prevalence of home blood pressure monitoring among hypertensive females and males - Polish Hypertension Survey (2001) (4)
ESH statement on detection and punishment of abstract fraud and poster plagiarism (2005) (4)
Renal denervation achieved by endovascular delivery of ultrasound in RADIANCE-HTN SOLO or by radiofrequency energy in SPYRAL HTN-OFF and SPYRAL-ON lowers blood pressure (2018) (4)
4A.01: LONG-TERM EFFECTS OF RENAL ARTERY DENERVATION IN REAL WORLD PATIENTS WITH UNCONTROLLED HYPERTENSION FROM THE GLOBAL SYMPLICITY REGISTRY (2015) (4)
Performance of 2014 NICE defibrillator implantation guidelines in heart failure risk stratification (2016) (4)
Ambulatory blood pressure and insulinaemia in different clinical conditions. (1996) (4)
Angiotensin-converting enzyme inhibitor therapy in patients non-obstructive coronary artery disease (2013) (4)
Principles governing heart failure therapy re-examined relative to standard evidence-based medicine-driven guidelines (2011) (4)
7D.07: RETINAL ARTERIOLAR STRUCTURE IN PATIENTS WITH PHEOCHROMOCYTOMA (2015) (4)
Thiol group identification at or near the agonist binding site of the vascular dopamine receptor. (1992) (4)
Persistent homology as a new method of the assessment of heart rate variability (2021) (4)
THE KIF6 719ARG ALLELE IS ASSOCIATED WITH INCREASED RISK OF CORONARY HEART DISEASE AMONG MALES IN THE WELCOME TRUST CASE CONTROL CONSORTIUM STUDY OF CORONARY HEART DISEASE (2009) (4)
SCORE model underestimates cardiovascular risk in hypertensive patients: Results of the Polish Hypertension Registry (2011) (4)
The α2C-Del322–325 adrenoceptor polymorphism and the occurrence of left ventricular hypertrophy in hypertensives (2012) (4)
Isolated Diastolic Hypertension in the IDACO Study: An Age-Stratified Analysis Using 24-Hour Ambulatory Blood Pressure Measurements (2021) (4)
A stunning day in hypertension research – Results of ONTARGET, ACCOMPLISH and HYVET (2008) (4)
EDITORIALHypertension and cardiovascular disease: Is arterial stiffness the heart of the matter? (2007) (4)
Screening for major cardiovascular risk factors among Members of Polish Parliament as a continuation of health marketing for effective cardiovascular prevention in Poland. Warsaw, May 2006. (2007) (4)
Subclinical macroangiopathic target organ damage in type 1 diabetes mellitus patients (2020) (3)
Urgent need to address quality control issues of out‐of‐office blood pressure measurement and patient risk assessment (2008) (3)
Increased urinary C-peptide and albumin excretion in juvenile borderline hypertensives. (1993) (3)
Impact of diabetes on long-term mortality after presentation with acute myocardial infarction. (2011) (3)
Elevated ambulatory systolic-diastolic pressure regression index is genetically determined in hypertensive patients with coronary heart disease (2017) (3)
The polypill: an emerging treatment alternative for secondary prevention of cardiovascular disease (2016) (3)
The abdominal obesity prevalence among hypertensives patients in Poland — the consequence of diagnostic criteria change in new Polish Society of Hypertension 2011 guidelines (2011) (3)
Beta-blocker therapy in patients with clinical evidence of heart failure after acute myocardial infarction (1998) (3)
Changes of augmentation index early after ischaemic stroke predict functional outcome (2020) (3)
Long-term survival benefit of ramipril in patients with acute myocardial infarction complicated by heart failure (2021) (3)
Identifying and treating resistant hypertension in PRECISION: A randomized long‐term clinical trial with aprocitentan (2022) (3)
The International Database of Central Arterial Properties for Risk Stratification: Research Objectives and Baseline Characteristics of Participants (2021) (3)
Mining Knowledge of Respiratory Rate Quantification and Abnormal Pattern Prediction (2021) (3)
The use of Transfer Entropy method for the assessment of cardiovascular regulation during head-up tilt test (2015) (3)
Monday, 27 August 2012 (2012) (3)
ACE-inhibitor therapy after myocardial infarction--a new treatment strategy. (1994) (3)
The five RADIANCE-HTN and SPYRAL-HTN randomised studies suggest that the BP lowering effect of RDN corresponds to the effect of one antihypertensive drug (2021) (3)
Agreement within Europe about antihypertensive treatment and education - results from the European Society of Hypertension questionnaire. (2010) (3)
Plasma insulin and blood pressure response to oral glucose tolerance test in young borderline hypertensives. (1993) (3)
Two-way FSI modelling of blood flow through CCA accounting on-line medical diagnostics in hypertension (2014) (3)
Unilateral carotid body resection in patients with resistant hypertension: a safety and feasibility trial (2016) (3)
Supplementary Material 5 (2014) (3)
‘ACE inhibitors are better than AT1 receptor blockers (ARBs)’ — controversies in heart failure (2000) (3)
ADHERENCE TO SECONDARY PREVENTION MEDICINES BY CORONARY ARTERY DISEASE PATIENTS -EXPLORING BARRIERS TO INFORM INTERVENTIONS (2012) (3)
[Obstructive sleep apnea and systemic hypertension]. (2007) (3)
Hypovolaemia-induced metabolic dysfunction, mediated in part by aldosterone and angiotensin. (2009) (3)
Supplementary Material 7 (2014) (3)
CLINICAL EVENT REDUCTIONS IN HIGH-RISK HYPERTENSION PATIENTS TREATED WITH RENAL DENERVATION: A MODEL-BASED ESTIMATE BASED ON 36-MONTH DATA FROM THE GLOBAL SYMPLICITY REGISTRY (2021) (3)
3B.05: COMPARISON OF INCIDENT HYPERTENSION, OVERWEIGHT AND OBESITY IN A REPRESENTATIVE POLISH JUNIOR HIGH-SCHOOL POPULATION IN 2005 VS. 2014 (2015) (3)
Insulin resistance and hypertension: lessons learned from studies in children. (2002) (3)
The International Society of Hypertension Guidelines 2020 – a new drug treatment recommendation in the wrong direction? (2020) (3)
Expertise: No Longer a Sine Qua Non for Guideline Authors? (2017) (3)
Supplementary Material 6 (2014) (3)
Modelling of subarachnoid space width changes in apnoea resulting as a function of blood flow parameters. (2017) (3)
The Relationship Between Gene Polymorphisms and Dipping Profile in Patients With Coronary Heart Disease. (2016) (3)
Hypertension and coronary artery disease: Mechanistic insights and therapeutic challenges (2005) (3)
Phenoxybenzamine mediated inhibition of the vascular dopamine D1 receptor. (1993) (3)
Managing comorbid cardiovascular disease and sleep apnea with pharmacotherapy (2018) (3)
2019 Guidelines for the Management of Hypertension — Part 8–9 (2019) (3)
Supplementary Material 3 (2015) (3)
The blood pressure lowering effects of renal denervation in a real world population of patients with uncontrolled hypertension: early outcomes from the Global SYMPLICITY registry (2013) (3)
Hypertension research into the new millennium (2010) (3)
FREQUENCY OF OBTURATIVE SLEEP APNEA AND OTHER COMMON SECONDARY HYPERTENSION CAUSES IN PATIENTS WITH TRUE RESISTANT HYPERTENSION: PP.32.291 (2010) (3)
Obesity and Obstructive Sleep Apnoea (2008) (2)
Sympathetic neural mechanisms in hypertension (2013) (2)
4C.08: AORTIC STIFFNESS IS AN INDEPENDENT BIOMARKER OF SUBCLINICAL BRAIN DAMAGE IN ACUTE ISCHEMIC STROKE. (2015) (2)
[Combination therapy in the management of hypertension - current problem in Poland. Expert consensus statement of the Polish Society of Hypertension and Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy]. (2013) (2)
Hypertension and obstructive sleep apnoea (2009) (2)
Genetic loci influencing C-reactive protein levels and coronary heart disease risk: results of genetic association and Mendelian randomisation study with meta-analysis in 80 614 people (2009) (2)
Recent advances in the pathophysiology of arterial hypertension: potential implications for clinical practice. (2017) (2)
Why albuminuria should be assessed more frequently in everyday clinical practice? Position statement. (2021) (2)
Management of High Blood Pressure in Intracerebral Haemorrhage (2016) (2)
Take a Blood Pressure Pill or Benefit from Renal Denervation? (2018) (2)
Do ACE Inhibitors Provide Protection for the Heart in the Clinical Setting of Acute Myocardial Infarction? (2012) (2)
The Sympathetic Nervous System in Hypertension (1999) (2)
Hypertension management during the COVID-19 pandemic: what can we learn for the future? (2022) (2)
Nurses' knowledge on the assessment of alcohol consumption and smoking and its effect on blood pressure (2013) (2)
RAS blockers: Does sex matter/ Re: Sex differences in the effectiveness of ARB and ACEI in patients with congestive heart failure — A population study: Marie Hudson et al. European Journal of Heart Failure 9 (2007) 602–609 (2007) (2)
8B.04: RENAL ARTERY DENERVATION FOR TREATMENT OF HYPERTENSIVE PATIENTS WITH OR WITHOUT OBSTRUCTIVE SLEEP APNEA AND RESISTANT HYPERTENSION RESULTS FROM THE GLOBAL SYMPLICITY REGISTRY (2015) (2)
Salt and arterial hypertension — epidemiological, pathophysiological and preventive aspects (2020) (2)
[Statement on the diagnosis and treatment of tobacco dependence in patients with cardiovascular diseases]. (2011) (2)
The evolution of ACE inhibition – A turning point in cardiovascular medicine (2007) (2)
Premature coronary artery disease shows no evidence of linkage to loci encoding for tissue inhibitors of matrix metalloproteinases (2003) (2)
TCT-84 Renal Denervation With Symplicity Spyral Catheter in the Global Symplicity Registry: Safety and Efficacy at 3 Years (2019) (2)
Antihypertensive therapy and cancer risks? (2011) (2)
Beta-2 adrenoreceptor gene polymorphisms and sympathetic outflow in humans (2011) (2)
A response to “Cardiovascular disease and obstructive sleep apnea: an underappreciated role for increased platelet activity?” (2018) (2)
Cognitive Dysfunctions in Type 1 Diabetes (2019) (2)
Clinical and Procedural Outcomes of Renal Artery Denervation In Real World Patients with Hypertension: An Update From the Global SYMPLICITY Registry (2013) (2)
ONTARGET, TRANSCEND and PROFESS – Clarifying, confusing or misleading (2009) (2)
A9 Relation between genetic variation at the angiotensinogen locus and waist-hip ratio, body mass index in normotensive subjects (1997) (2)
Angiotensin receptor blockers and endpoint protection (2005) (2)
Treatment strategies for comorbid conditions lower residual risk in patients with treated hypertension: FOURIER and other randomized outcome trials (2017) (2)
Daytime, home and office blood pressures in treated hypertensive patients according to accretion of cardiovascular risk (2006) (2)
THE DIGIT PREFERENCE PHENOMENON AND THE ASSESSMENT OF PREVALENCE OF HYPERTENSION: P1.135 (2000) (2)
Achieving better blood pressure control (2008) (2)
Was it optimal to drop a diuretic as a first-line choice of drug treatment in the 2020 International Society of Hypertension Guidelines? (2020) (2)
How to measure retinal microperfusion in patients with arterial hypertension (2020) (2)
Pharmacological characterization of the beta-adrenoceptor coupled to cyclic AMP formation, expressed by rat mesenteric artery vascular smooth muscle cells in culture. (1991) (2)
The application of persistent homology in the analysis of heart rate variability (2020) (2)
Exploring beliefs about medicines among adherent and non-adherent patients with coronary artery disease to establish medicines partnership (2013) (2)
Sympathetic neural responses to coronary occlusion during balloon angioplasty (2007) (2)
Pharmacological characterization of the DA1-dopamine receptor expressed by rat mesenteric artery vascular smooth muscle cells in culture (1989) (2)
Renal denervation in hypertension: is it the end or the beginning of a SPYRAL? (2017) (2)
[OP.7A.05] SLEEP DISTURBANCES AND RESISTANT HYPERTENSION IN A LARGE SAMPLE OF TREATED HYPERTENSIVE SUBJECTS – POL-FOKUS STUDY (2017) (2)
The PARAGON Heart Failure trial – ongoing investigation of the angiotensin receptor antagonist/neprilysin inhibitor sacubitril/valsartan in heart failure patients with hypertension and preserved ejection fraction (2019) (2)
Issues in the development of new combinations of blood pressure lowering drugs (2010) (2)
How ACE inhibitors reduce death from myocardial infarction: hypotheses from the AIRE study. Acute Infarction Ramipril Efficacy study. (1996) (2)
Angiotensin receptor blockers and cancer – Relationship dismissed by VALUE data while waiting for EMA and FDA reports (2010) (2)
Blood pressure variability: Emerging role in risk assessment and therapeutics (2010) (2)
HYPERTENSION PHENOTYPES DEFINED BY OFFICE AND AMBULATORY BLOOD PRESSURE IN 9,153 SUBJECTS REFERRED TO HYPERTENSION CLINICS IN FOUR CONTINENTS: THE ARTEMIS INTERNATIONAL REGISTRY: LB3.6 (2011) (2)
Clinical Event Reductions in High-Risk Patients After Renal Denervation Projected from the Global SYMPLICITY Registry. (2022) (2)
Blood pressure profile, sympathetic nervous system activity and subclinical target organ damage in patients with polycythemia vera. (2020) (2)
Predictive power of 24-h ambulatory pulse pressure and its components for mortality and cardiovascular outcomes in 11 848 participants recruited from 13 populations (2021) (2)
SHORT-TERM FUNCTIONAL OUTCOME AFTER ISCHEMIC STROKE IS RELATED TO BLOOD PRESSURE VARIABILITY (2018) (2)
Blood pressure control – Slowly getting there through new strategies? (2007) (2)
The phenomenon of HbA1c stability and the risk of hypoglycemia in long-standing type 1 diabetes. (2019) (1)
Abstract 11374: In Acute Coronary Syndromes, Heart-type Fatty Acid Binding Protein is a More Accurate Predictor of Long Term Prognosis than Troponin. (2010) (1)
Erratum: Meta-analysis of dense genecentric association studies reveals common and uncommon variants associated with height ((The American Journal of Human Genetics (2010) 88 (6-18)) (2012) (1)
Clinical outcome following percutaneous coronary intervention in patients with acute coronary syndromes and optimal platelet inhibition: results from a prospective registry of 864 patients (2013) (1)
419 Telomere length of circulating leukocytes is decreased in patients with chronic heart failure (2006) (1)
AIRE extension (AIREX) study - Reply (1997) (1)
The Relationship Between Plasma Angiopoietinlike Protein 4 Levels , Angiopoietinlike Protein 4 Genotype , and Coronary Heart Disease Risk (2010) (1)
Validity of a simple ST-elevation acute myocardial infarction risk index: are randomized trial prognostic estimates generalizable to elderly patients? (2003) (1)
The association of the chromosome 9p21 locus on risk of coronary artery disease is not mediated by an effect on telomere length (2009) (1)
Supplementary Material 15 (2013) (1)
Abstract 17557: Genetic Variants Primarily Associated eith Type 2 Diabetes Also Affect Coronary Artery Disease Risk (2012) (1)
1029-179 Left ventricular mass index and the common, functional, X-linked angiotensin II type 2-receptor gene polymorphism (1332 G/A) in patients with systemic hypertension (2004) (1)
Causal Effects of Adiposity on Cardiovascular Risk Factors (2015) (1)
Preserved efficacy of metoprolol in patients with heart failure homozygous for the hypofunctional gly389 variant of the beta1-adrenergic receptor (2000) (1)
Lower rates of heart failure and death in acute coronary syndromes. (2007) (1)
Supplementary Material 4 (2015) (1)
Intensive versus standard dose statin therapy: the costs and benefits for patients with acute coronary syndrome (2008) (1)
The role of angiotensin-converting enzyme inhibitors in coronary artery disease (2006) (1)
Supplementary Material 9 (2013) (1)
The role of adiposity in cardiometabolic traits (2013) (1)
Clinical Background to the Use of ACE Inhibitor Therapy after Myocardial Infarction (1995) (1)
What have the ACE-inhibitor trials in postmyocardial patients with left ventricular dysfunction taught us? (1996) (1)
Profile of documented medical history of chest-pain: a multicentre audit of 1,226 consecutive patients with validated acute MI (2005) (1)
Unraveling the ARB-MI Paradox Angiotensin Receptor Blockers May Increase Risk of Myocardial Infarction: (2007) (1)
Making the most of the Myocardial Ischaemia National Audit Project (MINAP) (2009) (1)
Exploitation of resources and procurement strategies (2007) (1)
Increasing prescription of drugs for secondary prevention of myocardial infarction (1996) (1)
Effect of ramipril after acute myocardial infarction in patients with arterial hypertension (1998) (1)
Reaching the wrong conclusion: residual confounding by indication (2018) (1)
SUBACUTE BLOOD PRESSURE VARIABILITY AND HEART RATE PREDICT FUNCTIONAL OUTCOME AFTER ISCHEMIC STROKE: 5B.06 (2011) (1)
Uric acid and xantine-oxidase inhibitors in patients with gout: A re-assessment and an update. (2019) (1)
Increased peripheral chemoreceptor sensitivity and exercise ventilation in heart transplant recipients (2005) (1)
A twin study shows strong heritability of plasma adiponectin levels and body mass index (2007) (1)
Negative correlation between fasting plasma insulin and ambulatory blood pressure in patients on chronic hemodialysis. (1993) (1)
Effects of hyperoxia on the relationship between heart rate variability, blood pressure and arterial wall properties in healthy subjects (2012) (1)
[LB.03.03] SYMPATHETIC NERVE ACTIVITY IS INDEPENDENTLY LINKED TO GEOMETRIC AND ELASTIC PROPERTIES OF COMMON CAROTID ARTERY IN RESISTANT HYPERTENSION (2017) (1)
146 Analysis of the diurnal blood pressure profile in normotensive twins (1993) (1)
TCT-762 Renal denervation treatment with the Symplicity Spyral multielectrode catheter: 6-month safety and blood pressure outcomes from the Global SYMPLICITY Registry. (2016) (1)
2015 Guidelines for the Management of Hypertension. Part 8 (2015) (1)
Erectile Dysfunction and Sleep Apnea (2015) (1)
The role of fixed-dose combinations in the treatment of hypertension — expert opinion (2011) (1)
Management of High Blood Pressure in Acute Ischaemic Stroke (2016) (1)
The INTERSALT Study and the complex relationship between salt intake and blood pressure (2017) (1)
The eye — a window to cardiovascular diseases (2020) (1)
TIME to face the reality about evening dosing of antihypertensive drugs in hypertension. (2022) (1)
The role of beta-blockers with vasodilative effect in the management of hypertension and its cardiovascular complications. Expert opinion (2010) (1)
Chapter 26 – Targeting Blood Pressure Lowering and the Sympathetic Nervous System (2015) (1)
There is a need for more aggressive implementation of combination strategies to control hypertensive risk (2007) (1)
Medical decision making in hypertension (2006) (1)
An appropriate SCORE to assess cardiovascular risk in hypertension? (2011) (1)
Cost‐effectiveness of blood pressure measurement and hypertension follow‐up (2006) (1)
Single-pill combinations, hypertension control and clinical outcomes: potential, pitfalls and solutions (2022) (1)
Post-registration studies for the evaluation of antihypertensive drugs (2011) (1)
Trends for beta-blockers use in a large cohort of Polish hypertensive patients — Pol-Fokus Study (2015) (1)
The relationship between endothelin-1 and blood pressure changes in obstructive sleep apnea (1998) (1)
The effect of diet on the risk of primary hypertension development. Dietary recommendations used in the prevention of arterial hypertension (2012) (1)
Intensive systolic blood pressure control and prevention of new onset atrial fibrillation in the SPRINT study: is the association really controversial? (2020) (1)
Effect of Maximal Breath Hold Apnea on Pial Artery Pulsation and Subarachnoid Width in Human (2016) (1)
Family history of hypertension: A novel and potent risk factor for premature coronary artery disease (2002) (1)
Hypertension Excellence Centres of the European Society of Hypertension (2006) (1)
Obstructive Sleep Apnea (2020) (1)
[OP.2A.08] RELATIONSHIP BETWEEN SELECTED DNA POLYMORPHISMS AND CORONARY ARTERY DISEASE COMPLICATIONS (2017) (1)
[Levels of insulin in serum during fasting and circadian blood pressure profile in young health men]. (1993) (1)
Prevalence and main features of resistant hypertension in central and eastern Europe: the BP-CARE Study (2012) (1)
Alcohol and syncope (2001) (1)
1A.10: ASSOCIATION BETWEEN GENE POLYMORPHISMS AND RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH CORONARY HEART DISEASE (2015) (1)
PULSE WAVE VELOCITY CHANGES AFTER ACUTE ISCHEMIC STROKE (2019) (1)
Management of dyslipidemia in Poland: Interdisciplinary Expert Position Statement endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy. The Fourth Declaration of Sopot (2021) (1)
SUBGROUP ANALYSIS OF LONG-TERM BLOOD PRESSURE REDUCTION IN THE GLOBAL SYMPLICITY REGISTRY (2019) (1)
PREVALENCE OF DIASTOLIC LEFT VENTRICULAR DYSFUNCTION IN EUROPEAN POPULATIONS BASED ON CROSS-VALIDATED DIAGNOSTIC THRESHOLDS: PP.40.296 (2011) (1)
8A.02: THE ASSOCIATION OF LEFT VENTRICULAR AND ATRIAL STRUCTURE WITH BODY COMPOSITION IMPACT AND PITFALLS OF SCALING IN POPULATION BASED STUDIES (2015) (1)
SMOKING AND OBESITY ASSOCIATED BDNF GENE VARIANCE PREDICTS TOTAL AND CARDIOVASCULAR MORTALITY IN SMOKERS (THE CARENORTH CONSORTIUM): 9D.07 (2011) (1)
RELATIONSHIP BETWEEN CAROTID ARTERY PROPERTIES, MUSCLE SYMPATHETIC NERVE ACTIVITY AND CARDIOVASCULAR VARIABILITY: 8B.07 (2011) (1)
CKD LAB METHODS, PROGRESSION & RISK FACTORS 1 (2014) (1)
Pet Ownership and the Risk of Arterial Hypertension and Cardiovascular Disease (2022) (1)
In memoriam: Jiří Widimský Sr. 1925–2020 (2020) (1)
Better drug adherence improves blood pressure control and lowers cardiovascular disease outcomes – from single pill combinations to monitoring of a nationwide health insurance database (2021) (0)
Prevalence of postural hypotension in patients with treated hypertension (2005) (0)
TCTAP A-048 Reduction of Clinical Events in High-Risk Hypertension Patients Treated With Renal Denervation: A Modeled Estimate From 36-Month Global SYMPLICTY Registry Data (2022) (0)
A7958 Prevalence and clinical characteristics of patients with treatment resistant hypertension by region: the spirit study (2018) (0)
[PS 03-25] ELEVATED AMBULATORY SYSTOLIC-DIASTOLIC PRESSURE REGRESSION INDEX IS GENETICALLY DETERMINED IN PATIENTS WITH CORONARY HEART DISEASE (2016) (0)
EFFECTS OF RENAL DENERVATION IN PATIENTS WITH VERSUS WITHOUT CHRONIC KIDNEY DISEASE (2019) (0)
ACE-INHIBITORS AND CARDIOPROTECTION OPEN ISSUES AND FUTURE SOLUTIONS Summary of Presentations from the Menarini Symposium , ESC Annual Congress 2013 , Amsterdam , the Netherlands Chairperson (2013) (0)
CARDIOVASCULAR RISK PROFILE IN YOUNG PATIENTS WITH EPILEPSY (2021) (0)
2020 ESC Digital Experience congress – what is new? (2020) (0)
Short-Term Heart Rate Variability and Functional Outcome After Acute Ischemic Stroke: 5b.04 (2011) (0)
2C.06: BLOOD PRESSURE CONTROL IN THE CONTEXT OF SCREENING FOR COGNITIVE AND MOOD IMPAIRMENTS IN THE OCTOGENARIAN AND OLDER HYPERTENSIVE PATIENTS (2015) (0)
Ambulatory pulse pressure and its contributors in autosomal dominant polycystic kidney disease. (2022) (0)
The 2018 European guidelines: tailoring treatment to new hypertension goals (2019) (0)
Mathematical Treatment of Autonomic Oscillations - 2 Response (1999) (0)
OUTCOME-BASED THRESHOLD FOR CAROTID-FEMORAL PULSE WAVE VELOCITY: THE IDCARS STUDY (2022) (0)
HEALTH-RELATED QUALITY OF LIFE IN CONTROLLED, UNCONTROLLED OR RESISTANT HYPERTENSION IN AMBULATORY TREATED PATIENTS – THE POL-FOKUS STUDY (2019) (0)
High mortality explained by mildly elevated blood pressure in Scandinavian adolescent conscripts – A plea for early drug treatment? (2011) (0)
The relationship between ACE and angiotensinogen gene polymorphisms and visceral obesity, and left ventricular structure and function — a 10-year follow-up of young healthy males (2011) (0)
Assessment of cardiovascular risk in hypertensives with white coat effect vs. patients with masked uncontrolled hypertension (2015) (0)
How to deal with the occurrence of rare drug-induced adverse events: the example of sprue-like enteropathy induced by olmesartan medoxomil and other angiotensin-receptor blockers (2020) (0)
Cardiovascular risks in HIV patients (2010) (0)
More focus on therapeutic targets and improved tolerability in hypertension (2008) (0)
[LB.03.01] AGE-DEPENDENT SYMPATHETIC NEURAL RESPONSES TO BETA-1 SELECTIVE BETA-BLOCKADE IN UNTREATED HYPERTENSION-RELATED TACHYCARDIA (2017) (0)
Awareness of the role of cardiovascular risk factors and their prevention – comparison between rural-urban and urban adolescents (2020) (0)
The data-based model of interaction between the respiratory and cardiovascular systems (2020) (0)
THE INFLUENCE OF NORMAL SLEEP AND OBSTRUCTIVE SLEEP APNEA ON CORONARY ARTERY ENDOTHELIAL CELLS MIGRATION: PP.6.237 (2010) (0)
Hemodynamic phenotypes and its association with blood pressure changes at continuous positive airway pressure therapy in obstructive sleep apnoea hypertensive patients (2018) (0)
SYMPATHETIC NERVE ACTIVITY IN SUBJECTS WITH HIGH-NORMAL BLOOD PRESSURE: OP 010 (2004) (0)
Masked hypertension in type 2 diabetes: never take normotension for granted and always assess out-of-office blood pressure (2022) (0)
PP.10.20: UNTARGETED METABOLOMICS WITH LC-TOF/MS IN STUDIES ON MECHANISMS UNDERLYING EARLY VASCULAR AGEING (2015) (0)
Pathophysiology of Subclinical Brain Damage in Hypertension: Large Artery Disease (2016) (0)
[JUPITER study, more reason to give statins as preventive measure - commentary]. (2009) (0)
THE INFLUENCE OF HYPOXIA ON THE REACTIVE OXYGEN SPECIES PRODUCTION IN GRANULOCYTES OF NORMAL AND OBSTRUCTIVE SLEEP APNEA PATIENTS: PP.10.260 (2011) (0)
LUMEN NARROWING OF RETINAL ARTERIOLES IS A VALUABLE BIOMARKER OF CARDIAC DAMAGE (2019) (0)
The Role of the Brain in Neurogenic Prehypertension (2018) (0)
CIRCADIAN RHYTHM OF BLOOD PRESSURE IS RELATED WITH HEART RATE BUT NOT GLUCOSE VARIABILITY IN LONG-STANDING TYPE 1 DIABETES (2018) (0)
Predictive Accuracy and Clinical Utility of Machine Learning Prediction for Classifying Blood Pressure Status (2022) (0)
AORTIC STIFFNESS IS NOT ONLY ASSOCIATED WITH STRUCTURAL BUT ALSO WITH FUNCTIONAL PARAMETERS OF MICROCIRCULATION (2019) (0)
Periodic breathing in short-term day-time recordings in hypertensive and normotensive individuals alters blood pressure parameters (2015) (0)
Status of the UPRIGHT-HTM trial in Gdańsk, Poland. (2022) (0)
[The influence of 5-week relaxation therapy on psychological state of patients with borderline hypertension]. (1998) (0)
PP.34.20: BLOOD PRESSURE VARIABILITY IS ASSOCIATED WITH STROKE LESION GROWTH (2015) (0)
Supine blood pressure normalised by daytime series values is independently associated with ischaemic wake-up stroke (2022) (0)
LACK OF RELATIONSHIP BETWEEN RESTING MUSCLE SYMPATHETIC NERVE TRAFFIC AND ESTIMATES OF SPONTANEOUS BAROREFLEX SENSITIVITY: P1.168 (2004) (0)
The question of whether diabetes and its cardiovascular risks can be prevented: A realistic DREAM? (2006) (0)
Nowe zalecenia europejskie dotyczące nadciśnienia tętniczego — najważniejsze aspekty diagnostyczne i terapeutyczne New European guidelines on hypertension — key diagnostic and therapeutic aspects (2013) (0)
WHAT DO OUR PATIENTS REALLY UNDERSTAND -SPEECH COMPREHENSION ASSESSMENT IN HYPERTENSIVE PATIENTS WITH A HISTORY OF STROKE: P1.323 (2004) (0)
Combining proteomics, home blood pressure telemonitoring and patient empowerment to improve cardiovascular and renal protection (2021) (0)
LC-MS analysis of non-targeted and targeted metabolic patterns in cancer and cardiovascular diseases (2013) (0)
Treatment of hypertension in patients with concomitant benign prostatic hyperplasia (2009) (0)
Nurses’ knowledge about the principles of measuring blood pressure and factors determining its value (2012) (0)
PARENTAL HYPERTENSION IS AN INDEPENDENT RISK FACTOR FOR CORONARY ARTERY DISEASE. POLISH HYPERTENSION SURVEY: 1B.7 (2000) (0)
[OP.3C.06] DIFFERENCE IN SUBACUTE BLOOD PRESSURE BETWEEN OFFICE AND AMBULATORY VALUES PREDICTS FUNCTIONAL OUTCOME AFTER ISCHEMIC STROKE (2016) (0)
FP067ASCANNING LASER DOPPLER FLOWMETRY OF RETINAL BLOOD FLOW IN EARLY STAGE AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (2018) (0)
Implementation of 24-hour Blood Pressure Control (2010) (0)
Effects of smoking tobacco on blood pressure and nursing actions (2013) (0)
PP.LB03.02: SINGLE NUCLEOTIDE POLYMORPHISMS CONTRIBUTES TO LEFT VENTRICULAR DIASTOLIC FUNCTION IN HYPERTENSIVE SUBJECTS (2015) (0)
[PP.07.03] GENETIC RISK SCORE AND DIPPING PROFILE IN HYPERTENSIVE PATIENTS WITH CORONARY HEART DISEASE (2016) (0)
CONTRIBUTION OF SYMPATHETIC NEURAL ACTIVITY TO 24-HOUR BLOOD PRESSURE VARIABILITY: P2.189 (2000) (0)
The inheritance of common carotid artery function assessed by pulsed wave spectral doppler and color velocity imaging. (1996) (0)
The myocardial infarction associated CDKN2A/CDKN2B locus on chromosome 9p21 is associated with stroke independently of cardiovascular risk factors and coronary events in patients with hypertension (2008) (0)
MUSCLE SYMPATHETIC NERVE ACTIVITY IS NOT INFLUENCED BY LONG-TERM SLOW BREATHING TRAINING IN HYPERTENSION: 9C.02 (2011) (0)
RISK STRATIFICATION BY CROSS-CLASSIFICATION OF CENTRAL AND BRACHIAL SYSTOLIC BLOOD PRESSURE. (2022) (0)
SYMPATHETIC NERVE ACTIVITY CHANGES FOLLOWING ACUTE EXPOSURES TO ELECTRONIC AND TOBACCO CIGARETTE SMOKING IN HUMANS (2021) (0)
Aspirin and mortality in patients with Diabetes Mellitus sustaining Acute Coronary Syndrome (2007) (0)
Abstract 19518: The Association of Telomere Length and Major Adverse Cardiac Events Among Patients With Obstructive Sleep Apnea (2016) (0)
Key questions regarding the SYMPLICITY HTN-3 trial (2023) (0)
Contents (2020) (0)
European Society of Hyperten sion Working Group on Obesity: obesity drugs and cardiovascular outcomes (2010) (0)
IMPACT OF SHORT-TERM CONTINUOUS POSITIVE AIRWAY PRESSURE THERAPY ON LEFT VENTRICLE SYSTOLIC FUNCTION ASSESSED BY TWO-DIMENSIONAL STRAIN IMAGING IN HYPERTENSIVE PATIENTS WITH OBSTRUCTIVE SLEEP APNEA: PP.10.270 (2011) (0)
The use of minimum intervention in the primary prevention of arterial hypertension (2010) (0)
[LB.02.04] EFFECTS OF RENAL DENERVATION IN PATIENTS WITH VERSUS WITHOUT CHRONIC KIDNEY DISEASE: RESULTS FROM THE GLOBAL SYMPLICITY REGISTRY WITH FOLLOW-UP DATA OF 3 YEARS (2017) (0)
TCT CONNECT-419 Patients With Resistant Hypertension in the Global SYMPLICITY Registry: Antihypertensive Medication Burden and Changes in Blood Pressure out to 3 Years (2020) (0)
[OP.4A.04] NON-INVASIVE HEMODYNAMIC MONITORING AS A GUIDE TO DRUG TREATMENT OF UNCONTROLLED HYPERTENSIVE PATIENTS: HOME BLOOD PRESSURE IN THE BEAUTY STUDY (2017) (0)
The surge of Japanese studies supporting the use of angiotensin receptor blockers in hypertension (2009) (0)
PS-C36-6: REAL-WORLD ANALYSIS OF ADHERENCE, OUTCOMES AND HEALTHCARE COSTS OF THE QUADRUPLE COMBINATION PERINDOPRIL, INDAPAMIDE, AMLODIPINE AND BISOPROLOL IN ITALY (2023) (0)
Does GISSI-AF change the concept of using RAS inhibitors in the primary prevention of atrial fibrillation in hypertensive patients? (2009) (0)
[10th anniversary of "Klub 30"]. (2005) (0)
Who is an expert? Reply (2017) (0)
Behandlung der Hypertonie bei Patienten mit Chronic Obstructive Pulmonary Disease (COPD) (2013) (0)
CONTRIBUTION OF ABDOMINAL OBESITY AND AMBULATORY BLOOD PRESSURE TO LEFT ATRIUM SIZE: A 10-YEAR FOLLOW-UP OF YOUNG NORMOTENSIVE SUBJECTS: 1D.08 (2011) (0)
Rebuttal from L. E. K. Ratcliffe, W. Pijacka, F. D. McBryde, A. P. Abdala, D. J. Moraes, P. A. Sobotka, E. C. Hart, K. Narkiewicz, A. K. Nightingale and J. F. R. Paton (2014) (0)
Title: Longterm survival benefit of ramipril in patients with acute myocardial infarction complicated by heart failure (2021) (0)
Impact of slow breathing on the blood pressure and subarachnoid space width oscillations in humans (2019) (0)
INCREASED SYMPATHETIC NERVE ACTIVITY IN SUBJECTS WITH HIGH-NORMAL BLOOD PRESSURE: P1.177 (2004) (0)
[PP.29.26] AORTIC STIFFNESS IS INDEPENDENTLY RELATED TO INTRACRANIAL ATHEROSCLEROSIS IN PATIENTS WITH ISCHEMIC STROKE (2017) (0)
Blood pressure medication should not be routinely dosed at bedtime. We must disregard the data from the HYGIA project. (2020) (0)
Improvement of Hypertension Control and Knowledge about the Disease in Patients Involved in Educational Programs of Polish Society of Hypertension (2001) (0)
Primary cardiovascular prevention by Mediterranean diet – The PREDIMED trial (2013) (0)
Novel approaches to diagnosis and treatment of sleep apnea (2011) (0)
Ordinal pattern statistics for RR intervals during head-up tilt test in patients with the history of vasovagal syncope (2014) (0)
EDUCATIONAL PROGRAM IMPROVES PATIENTS COMPLIANCE AND AMBULATORY BLOOD PRESSURE CONTROL IN HYPERTENSIVE PATIENTS WITH A HISTORY OF STROKE: P1.317 (2004) (0)
Plant stanols - underestimated component of diet in prophylasis and therapy of atherosclerotic cardiovascular disease (2010) (0)
Aortic stiffness is related to cerebral lesion growth in patients with acute ischemic stroke (2015) (0)
Corrigendum to “Pulse wave velocity is associated with early clinical outcome after ischemic stroke” [Atherosclerosis 225 (2) (2012) 348–52] (2013) (0)
Documentation of endpoint prevention with combination therapy in hypertension is urgently needed (2007) (0)
Blood Pressure in 2016: increased impact factor and change of editors (2016) (0)
Smoking, Nicotine and Blood Pressure (2012) (0)
[Asymptomatic disorders of autonomic circulatory system regulation --frequent diabetes complications, but without prognostic significance in patients treated optimally]. (2009) (0)
Poster session Friday 13 December - AM: 13/12/2013, 08:30-12:30 * Location: Poster area (2013) (0)
Direct renin inhibitors in hypertension – Approaching the moment of truth (2012) (0)
Application of win ratio methodology in the Global SYMPLICITY Registry for patients with atrial fibrillation or obstructive sleep apnea (2021) (0)
A18355 Age- sex- and ethnicity-specific prediction of cardiovascular outcomes by in-office and out-of-the-office blood pressure: a subject-level meta-analysis of 17,383 adults enrolled in 17 population studies (2018) (0)
Large gender differences in cardiovascular risk and in willingness to take park in preventive activities call for action—Results of the Polish 400 cities project (2006) (0)
Peter Meredith (2016) (0)
Heart rate variability is related to concomitant glucose fluctuation in longstanding type 1 diabetes (2018) (0)
THE RELATIONSHIP BETWEEN LEFT VENTRICULAR DIASTOLIC FUNCTION AND ARTERIAL STIFFNESS IN NORMOTENSIVE MALES: P2.176 (2004) (0)
C1: Sympathetic and chemoreflex responses to hypoxia and hypercapnia in normotensive patients with obstructive sleep apnea (1997) (0)
Blood Pressure celebrates 20 years of dedication to Nordic hypertension research (2010) (0)
Genetics and Pharmacogenomics (2008) (0)
Respiratory-circulatory interactions in obstructive sleep apnea (2001) (0)
Evaluation of potential benefits resulting from reaching target goals in type 2 diabetics treated in general practice (2006) (0)
Gajjala, P. R. et al. (2017) Proteomic-biostatistic integrated approach for finding the underlying molecular determinants of hypertension in human (2017) (0)
Blood pressure target in patients with hypertension and type-2 diabetes older than 65 years. Is <130/80 mmHg the right target or an excessive objective preventing from achieving the clinical goals we are aiming at? (2021) (0)
[PP.08.17] COMPARISON OF FOUR QUESTIONNAIRES IN EVALUATING THE PREVALENCE OF HIGH INDEX OF CLINICAL SUSPICION OF OSA IN TREATED HYPERTENSIVE PATIENTS - DATA FROM THE POL-FOKUS STUDY (2017) (0)
Lerkanidipina w leczeniu nadciśnienia tętniczego i jego powikłań sercowo-naczyniowych Lercanidipine in the treatment of arterial hypertension and its cardiovascular complications (2012) (0)
BLOOD PRESSURE REDUCTION AFTER CATHETER-BASED RENAL DENERVATION IN PATIENTS WITH CARDIOVASCULAR DISEASE IN THE GLOBAL SYMPLICITY REGISTRY (2022) (0)
The influence a community nursing course has on the selected knowledge of nurses with regard to rules for measuring blood pressure (2009) (0)
TCT-559 Influence of Gender on Blood Pressure Reduction After Renal Denervation in GSR DEFINE (2022) (0)
The PARAGON-Heart failure trial – another disappointment for heart failure patients with hypertension and preserved ejection fraction (2019) (0)
ESH statement on detection and punishment of abstract fraud and poster plagiarism. (2006) (0)
PP.34.24: ALTERED BRAIN MECHANISMS OF HIGHER COGNITIVE PROCESSING IN ESSENTIAL HYPERTENSION (2015) (0)
[PP.10.10] GENDER IN RESISTANT HYPERTENSION: IMPACT ON CLINICAL MANIFESTATIONS, ASSOCIATED FACTORS AND HYPERTENSION TREATMENT (2016) (0)
4.7 Heritability of Plasma Lipoprotein-Associated Phospholipase A2 (Lp-PLA2): a New Marker of Cardiovascular Risk (2008) (0)
TRADITIONAL SPHYGMOMANOMETRY UNDERESTIMATES IMPACT OF WAIST CIRCUMFERENCE CHANGE ON BLOOD PRESSURE: A 10-YEAR FOLLOW-UP OF YOUNG INITIALLY NORMOTENSIVE SUBJECTS (2004) (0)
144. Influence of 5-weeks relaxation therapy on 24-h ambulatory blood pressure and psychological state in borderline hypertension (1991) (0)
SMOKING IS ASSOCIATED WITH CHRONIC SYMPATHETIC ACTIVATION IN HYPERTENSION: 9C.05 (2010) (0)
[OP.8B.07] UTILITY OF SLEEP-POLYGRAPHIC STUDIES IN TERTIARY-CARE HYPERTENSION OUT-PATIENT CLINIC (2016) (0)
Heart rate variability and sleep (2016) (0)
Vascular Aging and Damage in Patients with Iron Metabolism Disorders (2022) (0)
Final Farewell to Alberto Zanchetti MD. (2018) (0)
Blood pressure determinants. Part I: Structure — function links in blood pressure regulation. Reliability of blood pressure measurement (2000) (0)
ASCOT – More than a horse race! (2005) (0)
TIMES TO ACT. Italian-Spanish-Polish-Uzbek Expert Forum Position Paper 2022. Dyslipidemia and arterial hypertension: The two most important and modifiable risk factors in clinical practice (2022) (0)
Invited review Hypertension and obstructive sleep apnoea (2009) (0)
Blood pressure determinants. Part II. Application of some physical laws in the hemodynamics of cardiovascular system (2004) (0)
OUTCOME-DRIVEN THRESHOLDS OF CENTRAL SYSTOLIC BLOOD PRESSURE AND CROSS-CLASSIFICATION OF SYSTOLIC HYPERTENSION AT CENTRAL AND BRACHIAL ARTERIES (2021) (0)
[Circadian rhythm of blood pressure and heart rate in hypertension with type 2 diabetes mellitus]. (1993) (0)
PCV5 The Effeects of Statins on Blood Presure in Normotensive or Hypertensive Subjects-a Meta-Analysis of 18 Randomized Controlled Trials Involving 5628 Participants (2012) (0)
ACEI and ARB - Each Unique RAAS Inhibitors: The Importance of Impact on Inflammation. (2023) (0)
SO037AMBULATORY BLOOD PRESSURE IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE - IMPROVING DIAGNOSIS AND OPTIMIZING THERAPY (2020) (0)
HYPERTENSION IN ATHLETES (2009) (0)
Restoration of sinus rhythm does not improve peripheral blood flow in hemodynamically stable patients with atrial fibrillation (2019) (0)
[Spectrum analysis of heart rate. A method of studying the role of the autonomic nervous system in the regulation of blood circulation]. (1991) (0)
Diagnosis and treatment of hypertension in patients with diabetes (2006) (0)
APPLICABILITY OF BERLIN QUESTIONNAIRE FOR OBSTRUCTIVE SLEEP APNEA DIAGNOSIS IN HYPERTENSIVE PATIENTS WITH TYPE2 DIABETES: PP.10.277 (2011) (0)
Sleep-disordered breathing as a risk factor for hypertension and cardiovascular morbidity (2003) (0)
Ambulatory Blood Pressure Adds to Explaining Benefits of AT‐1 Receptor Blockade in the Treatment of Left Ventricular Hypertrophy (2007) (0)
[Significant negative correlation between fasting plasma insulin and ambulatory blood pressure in patients on chronic hemodialysis]. (1996) (0)
Revisiting the pre-hypertension debate: Increasing evidence for treatment – or not? (2013) (0)
Investigating the endothelin receptor antagonist aprocitentan in resistant hypertension: design and baseline characteristics of the PRECISION study (2021) (0)
The ninety-fifth annual general meeting of the association of physicians of Great Britain and Ireland 2001 (2001) (0)
Algoritmically improved microwave radar monitors breathing more acurrate than sensorized belt (2022) (0)
ASSOCIATION OF CARDIOVASCULAR ENDPOINTS AND MORTALITY WITH CENTRAL AND PERIPHERAL PULSATILE BLOOD PRESSURE COMPONENTS (2021) (0)
S-16-1: RESISTANT HYPERTENISION: CLINICAL CHARACTERISTICS AND BLOOD PRESSURE CONTROL (2023) (0)
C-reactive protein is not related to ambulatory blood pressure or target organ damage in treated hypertensives (2015) (0)
SAFETY AND EFFICACY OF BETA-BLOCKER THERAPY IN OBSTRUCTIVE SLEEP APNEA PATIENTS WITH HYPERTENSION: PP.32.278 (2010) (0)
ACEI and ARB - Each Unique RAAS Inhibitors: The Importance of Impact on Inflammation. (2023) (0)
Sacubitril/valsartan improved microvascular endothelial function in a young patient with COVID-19-related mild left ventricular dysfunction. (2022) (0)
WHEN TO START EDUCATION ABOUT HYPERTENSION ? CHANCE FOR THE YOUNG HEART. EDUCATION PROGRAM FOR 14 000 PUPILS IN 546 POLISH PRIMARY SCHOOLS: PP.20.265 (2010) (0)
55 Gene-gene interactions in coronary artery disease (2011) (0)
Ordinal pattern statistics for the assessment of heart rate variability (2013) (0)
METABOLIC PROFILE, PATTERNS OF METABOLIC CONTROL BY TREATMENT AND RELATIONSHIPS WITH BLOOD PRESSURE VALUES IN PATIENTS FROM CENTRAL AND EASTERN EUROPEAN COUNTRIES: THE BP-CARE METABOLIC STUDY: 1B.03 (2011) (0)
Assessment of respiratory pattern variability during wakefulness in subjects with sleep apnea (2022) (0)
Are acute coronary syndromes risk models too complex? Authors' reply (2007) (0)
A4699 Effects of renal denervation in patients with versus without chronic kidney disease: results from the Global Symplicity Registry with follow-up data of 3 years (2018) (0)
[What nurses with a bachelor of nursing degree know about the effects of alcohol on blood pressure and risk of arterial hypertension]. (2009) (0)
[PP.18.10] IMPACT OF SHORT-TERM CPAP TREATMENT ON DAY- AND NIGHTTIME ACTIVITY IN OBSTRUCTIVE SLEEP APNEA HYPERTENSIVE PATIENTS (2017) (0)
PP.06.39: GENETIC RISK SCORES AND VASCULAR STIFFNESS IN PATIENTS WITH ARTERIAL HYPERTENSION (2015) (0)
Abstract P195: Blood Presure is Related to Glucose Fluctuation in Longstanding Type 1 Diabetes (2018) (0)
[PP.23.15] RELATIONSHIP BETWEEN PATIENT CHARACTERISTICS, RISK FACTORS, FREQUENCY OF PRIMARY ALDOSTERONISM AND THE NUMBER OF ANTIHYPERTENSIVE DRUGS IN PATIENTS WITH TRUE RESISTANT HYPERTENSION (2016) (0)
Benefits of hypertension management in diabetes: An opportunity not to be missed (2008) (0)
MORNING BLOOD PRESSURE SURGE IS NOT RELATED TO MUSCLE SYMPATHETIC NERVE ACTIVITY IN HYPERTENSION: 9C.04 (2010) (0)
Effects of alcohol on hypertension and nursing practice (2012) (0)
Women's health, cardiovascular risk and hypertension: the perspective still needs to improve. (2023) (0)
1199Reduction in blood pressure following renal denervation for patients with differing baseline cardiovascular risk (2019) (0)
PP.37.07: IMPACT OF SHORT-TERM CPAP THERAPY ON LEFT VENTRICLE DIASTOLIC FUNCTIONAL PROPERTIES IN NEWLY-DIAGNOSED OBSTRUCTIVE SLEEP APNEA PATIENTS WITH HYPERTENSION (2015) (0)
HEART RATE VARIABILITY, LARGE VESSEL REMODELLING AND METABOLIC PARAMETERS IN STAGE 1 HYPERTENSION ACCORDING TO THE ACC/AHA 2017 GUIDELINES (2018) (0)
[Evaluation of blood pressure changes and heart rate in young health men based on results of a 24-hour monitoring of pressure]. (1991) (0)
Ischemic heart disease : the next target for the angiotensin-converting enzyme inhibitors (2003) (0)
[Polymorphism of the ACE gene and left ventricular morphology and function in patients with borderline, mild and moderate hypertension]. (1998) (0)
SHORT-TERM CONTINUOUS POSITIVE AIRWAY PRESSURE THERAPY IMPROVES LEFT AND RIGHT VENTRICLE DIASTOLIC FUNCTION IN HYPERTENSIVE PATIENTS WITH OBSTRUCTIVE SLEEP APNEA: PP.32.282 (2010) (0)
Doppler indexes of left ventricular systolic and diastolic function in relation to the arterial stiffness and wave reflection in a general population (2016) (0)
Common Strategies and Factors Affecting Off-Line Breath Sampling and Volatile Organic Compounds Analysis Using Thermal Desorption-Gas Chromatography-Mass Spectrometry (TD-GC-MS) (2022) (0)
The prevalence of high blood pressure readings in children and adolescents attending primary and secondary schools in Kwidzyn (2009) (0)
[PP.07.02] AMBULATORY SYSTOLIC-DIASTOLIC PRESSURE REGRESSION INDEX IS GENETICALLY DETERMINED IN HYPERTENSIVE PATIENTS WITH CORONARY HEART DISEASE (2016) (0)
[OP.LB03.02] NON-INVASIVE HEMODYNAMIC MONITORING IN UNCONTROLLED HYPERTENSIVE PATIENTS: EFFECT ON ARTERIAL STIFFNESS AND CENTRAL BLOOD PRESSURE THE BEAUTY STUDY (2016) (0)
[The role of medical university in modern prevention of cardiovascular diseases. Examples from Medical University of Gdańsk]. (2005) (0)
Association between an estrogen receptor alpha polymorphism (ERA : rs2234693) and the metabolic syndrome and cardiovascular and cerebrovascular morbidity and mortality (2008) (0)
P4589Long-term risk for atrial fibrillation and daytime systolic blood pressure load (2017) (0)
Temporal increment distributions of RR-intervals reveal dynamics of cardiac regulation in head-up tilt test (2014) (0)
PULSE WAVE VELOCITY IS A PREDICTOR OF OUTCOME IN PATIENTS AFTER ISCHEMIC STROKE: PP.4.134 (2010) (0)
ARTERIAL STIFFNESS AND WAVE REFLECTION ANALYSIS IN PATIENTS WITH ACUTE ISCHEMIC STROKE: 3B.06 (2010) (0)
Temporal changes in complexity of cardiovascular regulation during head-up tilt test by entropic measures of fluctuations of heart period intervals and systolic blood pressure (2014) (0)
A18029 Outcome-Driven Thresholds for Ambulatory Blood Pressure Based on the New ACC/AHA Classification of Hypertension (2018) (0)
Impact of type 1 diabetes and its duration on wall-to-lumen ratio and blood flow in retinal arterioles. (2021) (0)
Executive self-control in patients with arterial hypertension – cognitive and neuroimaging parameters measured with selected neuropsychological tests and fMRI (2019) (0)
Increased time varying heart rate and cardiovascular risk in hypertension – Benefit of selective I(f) channel inhibitor? (2012) (0)
Abstract 12075: Mortality Rate after Left Main Stem Percutaneous Coronary Intervention for Different Clinical Syndromes. (2010) (0)
ANGIOTENSIN RECEPTOR BLOCKERS : MYOCARDIAL INFARCTION IS NOT REDUCED (2017) (0)
P45 Effective non-invasive prediction of cardiovascular disease (2016) (0)
Rare sequence variants that disrupt ASGR 1 function lower non-HDL cholesterol and protect against coronary artery disease (2016) (0)
A common VEGF polymorphism is associated with an impaired prognosis in patients with chronic heart failure : for the MERIT-HF study group (2004) (0)
ACE inhibition for the secondary prevention of myocardial infarction: a concise overview for clinical cardiologists (2014) (0)
Masked arterial hypertension in a 64-year-old man with primary aldosteronism (2021) (0)
The Effect of Beta-Blocker Therapy on Two Year Mortality in Patients Discharged after Myocardial Infarction with Clinical Evidence of Congestive Heart Failure (1999) (0)
Impact of age on 30-day survival from percutaneous coronary intervention for non-ST elevation myocardial infarction in 165 207 patients from the MINAP database (2009) (0)
[What nurses with a bachelor of nursing degree know about the classification of arterial blood pressure and sequellae of arterial hypertension]. (2009) (0)
Prevention of myocardial infarction with ACE inhibitors : a global need - (2015) (0)
The lipoprotein lipase gene serine 447 stop variant influences hypertension-induced LVH as well as exercise induced left ventricular growth (2006) (0)
Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants Myocardial Infarction Genetics Consortium * (2009) (0)
025 COMPOSITE QUALITY SCORES FOR CARE OF ACUTE MYOCARDIAL INFARCTION PATIENTS AT DISCHARGE FROM HOSPITAL: A STUDY OF 136 392 PATIENTS FROM THE MYOCARDIAL ISCHAEMIA NATIONAL AUDIT PROJECT (MINAP) (2013) (0)
Syddansk Universitet Variant ASGR1 associated with a reduced risk of coronary artery disease (2016) (0)
Abstract 14363: Genetics of Coronary Atherosclerotic Plaque Rupture and Myocardial Infarction (2010) (0)
Innovative 12 months ticagrelor virtual clinic – supporting appropriate extended dual anti-platelet therapy in post MI (2020) (0)
AN INVESTIGATION INTO THE EFFECT OF CYTOCHROME P450 (CYP) 2D6 GENOTYPE ON PHARMACOKINETICS, PHARMACODYNAMICS AND OUTCOMES DURING METOPROLOL CR/XL THERAPY IN A HEART FAILURE COHORT (2013) (0)
Abstracts from the 2015 Annual Scientific Meeting of the BHS (2015) (0)
Abstract 14132: The Association of Volume of Patients Admitted with ST Elevation Myocardial Infarction, and the Proportion receiving Primary Percutaneous Coronary Intervention, with Time Delays and Mortality: The Myocardial Ischaemia National Audit Project (MINAP) 2004-7. (2010) (0)
ACE INHIBITORS VERSUS ANGIOTENSIN II RECEPTOR BLOCKERS: THE WEIGHT OF THE EVIDENCE (2006) (0)
Critical aspects in hypertension diagnosis and treatment (2009) (0)
PP.37.08: OCCURRENCE OF SLEEP DISORDERED BREATHING AND CARDIOVASCULAR DISEASE IN ELDERLY, RURAL-URBAN POLISH POPULATION (2015) (0)
Does CRP Play a Causal Role in the Development of Coronary Heart Disease: Results of a Mendelian Randomisation Experiment Involving 128,935 People (2009) (0)
Lercanidipine in the treatment of arterial hypertension and its cardiovascular complications Summary (2012) (0)
Cardiac Neuromodulation Therapy – a novel device-based therapy for patients with hypertension and indications for pacing (2019) (0)
Utility of polygraphic studies for sleep apnea screening in the setting of tertiary care hypertension outpatient clinic (2016) (0)
1031-107 The vascular endothelial growth factor +405 CC promotor polymorphism is associated with an impaired prognosis in patients with chronic heart failure: For the MERIT-HF study group (2004) (0)
The role of fix-dose combination therapy: from hypertension to dyslipidaemia (2013) (0)
2.1 Polymorphisms leading to amino-acid changes in the angiotensin II type 1 receptor gene in a hypertensive population (1997) (0)
Sex differences in health-related quality of life trajectories following myocardial infarction: national longitudinal cohort study (2022) (0)
The Health Outcomes Prevention and Evaluation 4 (HOPE 4) project: A successful community-based intervention to lower cardiovascular risk in people with hypertension (2020) (0)
Assessment of body mass and its effect on blood pressure values according to nurses with a Bachelor of Nursing degree (2008) (0)
Abstract 1588: Worldwide Gender Bias in Angiographic Obstructive Acute Coronary Syndromes? (2009) (0)
Common carotid artery properties are related to sympathetic outflow and cardiovascular variability (2011) (0)
Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data (2019) (0)
“Real-time” quality of care monitoring for acute myocardial infarction (2003) (0)
68 Rare alleles in genetic predisposition to coronary artery disease: insights from the novel analysis of gene-centric array (2011) (0)
Supplementary Material (nature09270-s1) (2012) (0)
INCIDENCE OF OBSTRUCTIVE SLEEP APNEA AND COMMON SECONDARY HYPERTENSION CAUSES IN PATIENTS WITH TRUE RESISTANT HYPERTENSION: PP.10.273 (2011) (0)
[PP.17.01] INCREASED INSPIRATORY RESISTANCE AFFECTS THE CARDIAC CONTRIBUTION TO THE RELATIONSHIP BETWEEN BLOOD PRESSURE AND PIAL ARTERY PULSATION OSCILLATIONS (2016) (0)
Iritis prevention study: does topical flurbiprofen prevent recurrent iritis in patients at high risk? (2004) (0)
[PP.33.13] LEFT VENTRICLE DIASTOLIC FUNCTION IN A COHORT OF TREATED HYPERTENSIVE PATIENTS (2016) (0)
1029-184 The clinical significance of a common, functional, X-linked angiotensin II type 2-receptor gene polymorphism (-1322 G/A) in a cohort of 509 families with premature coronary artery disease (2004) (0)
Composite quality scores for care of acute myocardial infarction patients at discharge from hospital: a study of 136,392 patients from the Myocardial Ischaemia National Audit Project (MINAP) (2013) (0)
Coronary flow reserve: a new target for treating hypertension (2009) (0)
A1850 Blood pressure dipping status affects the relationship between glucose fluctuation and heart rate variability in type 1 diabetic patients (2018) (0)
RAAS Inhibitors and Risk of Covid-19. (2020) (0)
Cardiac rehabilitation improves long-term survival after acute coronary syndrome: (2006) (0)
Czynniki warunkuj"ce ciúnienie tŒtnicze. CzŒúÊ I: Powi"zania strukturalno-czynnoúciowe w regulacji ciúnienia tŒtniczego i wiarygodnoúÊ jego pomiaru Blood pressure determinants. Part I: Structure ó function links in blood pressure regulation. Reliability of blood pressure measurement (2000) (0)
Bleeding and platelet P2Y12 receptor inhibition following percutaneous coronary intervention for acute coronary syndrome (2013) (0)
Bidirectional information transfer between blood pressure and heart rate and its relation to vascular properties in hypertensive patients (2016) (0)
Abstract 554: Measurement of Heart-Type Fatty Acid Binding Protein Identifies High Risk Patients among Those with Suspected Acute Coronary Syndrome Who Are Troponin Negative (2008) (0)
Hypertension management in the COVID-19 era. Getaway from pandemic snares (2021) (0)
Blood-Pressure and Cholesterol Lowering in the HOPE-3 Trial. (2016) (0)
[PP.07.09] GENETIC RISK SCORE AND CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH HYPERTENSION (2016) (0)
Abstract 18356: The Breast Cancer Resistance Protein (BCRP) c.421C>A Single Nucleotide Polymorphism Increases Steady-state Plasma Concentration of Rosuvastatin (2010) (0)
Are acute coronary syndromes risk models too complex? (2007) (0)
The vascular endothelial growth factor +405 CC promotor polymorphism is associated with an impaired prognosis in patients with Chronic Heart Failure (2004) (0)
Sleep Disturbances/Sleep Apnea (2018) (0)
Edinburgh Research Explorer Secretory Phospholipase A2-IIA and Cardiovascular Disease (2018) (0)
Abstract 16055: Cardiovascular Sequelae in Long Term Survivors of Childhood Cancer. (2010) (0)
Edinburgh Research Explorer Novel loci associated with increased risk of sudden cardiac death in the context of coronary artery disease (2013) (0)
ARB & MI ongoing concerns (2018) (0)
Abstract 16094: RAB3 GTPase Activating Protein Subunit 1 is a Novel Candidate Gene for Sudden Cardiac Death (2012) (0)
RELATIONSHIP BETWEEN GENDER, FAT DISTRIBUTION, METABOLIC ABNORMALITIES AND OBSTRUCTIVE SLEEP APNEA IN TRUE RESISTANT HYPERTENSIVE PATIENTS: PP.10.271 (2011) (0)
WHAT ARE THE TRUE DIFFERENCES BETWEEN RENIN-ANGIOTENSIN SYSTEM INHIBITORS? CLINICAL TRIALISTʼS POINT OF VIEW: PP.15.450 (2011) (0)
and comparison survival in two cohorts collected in 1995 and 2003 The effect of referral for cardiac rehabilitation on survival following acute myocardial infarction : a (2014) (0)
Aortic stiffness indices in first-ever and recurrent ischemic stroke – A preliminary report (2011) (0)
evidence from the AIRE study heart failure after acute myocardial infarction : variables in patients with clinical evidence of Blocker treatment and other prognostic β (1998) (0)
Gene-gene interactions in coronary artery disease (2012) (0)
Prevalence of hypertension and metabolic disturbances in a population-based cohort of postmenopausal women. The Gniewkowo Women Study (2015) (0)
Hypertrophy: Recalibration Against Cardiac MRI New Gender-Specific Partition Values for ECG Criteria of Left Ventricular (2007) (0)
Need for multiple risk reduction strategies in clinical trials enrolling high risk patients - FOURIER investigating PCSK-9 inhibitor to lower cholesterol revisited (2019) (0)
Neural Mechanisms (2019) (0)
Missed opportunities across the pathway of care and mortality for eligible patients with ST-elevation myocardial infarction (2013) (0)
Relationship between ankle brachial index and other indices of target organ damage in hypertensive patients (2012) (0)
Abstract 3447: The Breast Cancer Resistance Protein (BCRP) 421C> A Single Nucleotide Polymorphism Predicts Improved Low-Density-Lipoprotein Cholesterol Reduction by Rosuvastatin (2008) (0)
Pdf for Approval - Ijc (2016) (0)
Metabolic profile and control by treatment and relationships with blood pressure values in patients from central and easter European countries: the BP-CARE metaboli study (2011) (0)
Time-Dependent Changes in Carotid-Femoral Pulse Wave Velocity in Patients After Ischemic Stroke: Pp.37.246 (2011) (0)
027 THE IMPACT OF STRATEGIC UK NATIONAL HEALTH SERVICE (NHS) FUNDING ON THE PATIENT RECRUITMENT TO ‘ATHEROTHROMBOSIS’ RESEARCH STUDIES. THE UK NHS ATHEROTHROMBOSIS RESEARCH NETWORK (2013) (0)
P-541: Importance of ventilation in modulating the interaction between sympathetic drive and cardiovascular variability (2001) (0)
Sympathetic Activation by Sildenafil: Response (2001) (0)
Expedited discharge with high-sensitivity (hs) troponin (2015) (0)
Y Chromosome Haplogroup as a Predictor of Coronary Artery Disease in Men (2010) (0)
Abstract 15963: Toward Development of a Genetic Risk Score for Sudden Cardiac Death (2014) (0)
AN INVESTIGATION INTO THE EFFECT OF CYTOCHROME P450 (CYP) 2D6 GENOTYPE ON PHARMACOKINETICS, PHARMACODYNAMICS AND OUTCOMES DURING METOPROLOL CR/XL THERAPY IN A HEART FAILURE COHORT: A MERIT-HF SUB-STUDY (2013) (0)
[PP.24.09] THE ROLE OF STRUCTURAL AND FUNCTIONAL ALTERATIONS OF LARGE ARTERIES IN VENTRICULAR HYPERTROPHY AND DIASTOLIC DYSFUNCTION IN PATIENTS WITH ESSENTIAL HYPERTENSION (2017) (0)
Implications of REACH for the cardiologist (2007) (0)
026 TRENDS IN IN-HOSPITAL TREATMENTS, INCLUDING REVASCULARISATION, FOLLOWING ACUTE MYOCARDIAL INFARCTION, 2003–2010: A MULTI-LEVEL AND RELATIVE SURVIVAL ANALYSIS FOR THE NATIONAL INSTITUTE FOR CARDIOVASCULAR OUTCOMES RESEARCH (NICOR) (2013) (0)
Abstract 14086: Investigation of Inflammatory Markers and Cardiac Events Following Discontinuation of Interleukin-1 Receptor Antagonist in NSTE-ACS Patients (2015) (0)
European Society of Hypertens ion Working Group on Obesity Obesity-induced hypertension and target organ damage: current knowledge and future directions (2009) (0)
Abstract 18993: Genetic Variants Primarily Associated With Inflammatory Bowel Disease Do Not Associate With Coronary Artery Disease (2014) (0)
Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension^Chinese Hypertension League Stroke in Hypertension OptimalTreatment randomized trial (2014) (0)
In Memoriam: Jiří Widimský Sr. 1925-2020. (2021) (0)
In memoriam: Peter Sleight 1929–2020 (2020) (0)
New ESH Hypertension Excellence centers approved (2008) (0)
treat hypertension more effectively through augmentation of patients ’ adherence to treatment — benefits of fixed combination therapy Summary (2008) (0)
[OP.8C.05] THE RELATIONSHIP BETWEEN RETINAL MICROCIRCULATION AND LARGE ARTERIES IN PATIENTS WITH ESSENTIAL HYPERTENSION (2017) (0)
Longitudinal Tracking of Muscle Sympathetic Nerve Activity and Its Relationship With Blood Pressure in Normotensive Subjects: 9c.05 (2011) (0)
SUBGROUP ANALYSIS IN THE GLOBAL SYMPLICITY REGISTRY (2019) (0)
CONTRASTING EFFECTS OF ALCOHOL ON SYMPATHETIC NERVE ACTIVITY IN HEALTHY MIDDLE-AGED VERSUS YOUNG SUBJECTS: P 005 (2004) (0)
In memoriam: Peter Sleight 1929-2020. (2020) (0)
Thirty years with LIFE—a randomized clinical trial with more than 200 published articles on clinical aspects of left ventricular hypertrophy (2022) (0)
Treatment of high blood pressure in acute stroke – The SCAST Study (2011) (0)
Characteristics of uncontrolled and resistant hypertensive patients treated by general practitioners and cardiologists in Poland - Polfokus study (2013) (0)
MICROALBUMINURIA IS A POOR MARKER OF VASCULAR DAMAGE IN HYPERTENSIVE PATIENTS WITHOUT CARDIOVASCULAR DISEASE: PP.13.360 (2011) (0)
The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevationacutecoronarysyndromes:theMRC-ILA (2014) (0)
Preparaty o przed‡u¿onym uwalnianiu leku w terapii nadciúnienia tŒtniczego: znaczenie kliniczne indapamidu SR 1,5 mg Sustained Release Formulations in the Treatment of Arterial Hypertension: Clinical Implications†of Indapamide SR 1.5 mg (2000) (0)
Is leptin the link between angiotensin-converting enzyme gene polymorphism and body mass index in untreated hypertensives? (2000) (0)
ISH NIA PS 03-06 Genetic risk score determines cardiovascular complications in patients with stable coronary artery disease (2016) (0)
Relation between interleukin-6 and homocysteine in type 2 diabetes mellitus (2000) (0)
[The influence of 5-week relaxation therapy on arterial blood pressure in patients with borderline hypertension]. (1998) (0)
ARTERIAL STIFFNESS GRADIENT PREDICTS INDEPENDENTLY FUNCTIONAL OUTCOME AFTER ISCHEMIC STROKE (2022) (0)
PLATELET FUNCTION TESTING AND HEART-TYPE FATTY ACID BINDING PROTEIN LEVELS FOR RISK STRATIFICATION IN PATIENTS WITH ACUTE CORONARY SYNDROME WHO UNDERGO PERCUTANEOUS CORONARY INTERVENTION (2015) (0)
Wednesday, 29 August 2012 (2012) (0)
[BP.05.05] COEXISTENCE OF SLEEP DISTURBANCES IN TREATED HYPERTENSIVE SUBJECTS - RESULTS OF POL-FOKUS STUDY (2017) (0)
20 Influence of postural change on the sympathovagal balance, estimated by power spectral analysis of heart rate nervous variability in normal subjects (1993) (0)
Cardiovascular Effects of Tobacco emodynamic and Autonomic Effects of mokeless Tobacco in Healthy Young Men (2016) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Krzysztof Narkiewicz?

Krzysztof Narkiewicz is affiliated with the following schools:

Krzysztof Narkiewicz's Academic­Influence.com Rankings

Krzysztof Narkiewicz's Degrees

Why Is Krzysztof Narkiewicz Influential?

Krzysztof Narkiewicz's Published Works

Published Works

What Schools Are Affiliated With Krzysztof Narkiewicz?

Krzysztof Narkiewicz's AcademicInfluence.com Rankings